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Mycobacterium tuberculosis (Mtb) infection results in the formation of a granuloma 
by the host immune response.  The well-structured tuberculous (TB) granuloma 
confines the bacilli at the local foci, preventing the systemic infection.  Most of Mtb-
infected individuals are able to control the infection and stay healthy.  However, by 
still unknown mechanisms, the TB granuloma can liquefy and erode into the airway 
space, thereby releasing bacilli and transmitting TB to other hosts.  Despite the 
importance of granulomas in TB pathogenesis, our understanding is still unclear. 
This work was performed to advance our knowledge on the biology of TB granuloma 
by using human TB tissues and in vitro and in vivo models.  
Our microarray analysis on human TB granulomas shows upregulation of biological 
processes including inflammation, lipid metabolism, tissue remodeling, and apoptosis.   
Immunohistological analysis on human TB lung tissues reveals that proteins 
responsible for lipid synthesis and accumulation are disproportionately expressed in 
granulomas; adipose differentiation-related protein (ADFP), acyl-CoA synthetase long 
chain family member 1 (ACSL1), and saposin C (SapC) are most strongly expressed 
in caseous granulomas but not in resolved granulomas.  The biochemical analysis 
shows that the caseum of TB granulomas is enriched with neutral lipids and 
glycosphingolipids, which are tightly associated with the upregulated expression of 
ADFP, ACSL1, and SapC.  In addition, Mtb infection in macrophages in vitro induces 
similar changes of transcript and protein expression when compared to that of human 
pulmonary TB granulomas, suggesting that the host lipid metabolism is perturbed by 
 Mtb infection.  Furthermore, murine granulomas induced by the Mtb-cell wall 
component, trehalose dimycolate (TDM), accumulate extensive amounts of lipids in 
cells, and this phenomenon is not dependent on the presence of B- or T-cells, 
indicating that innate immunity is mainly responsible for the accumulation of lipids in 
cells in response to TDM.  In addition to lipid accumulation, the microarray analysis 
shows that the murine TDM-granuloma is strikingly reminiscent of human TB 
granuloma; e.g. tissue remodeling and degeneration, cell death, and angiogenesis.      
In summary, these data demonstrate (1) human TB granulomas undergo dysregulated 
lipid metabolism, which culminates in the formation of lipid-filled caseum, (2) Mtb 
bacilli infection affects the lipid metabolism in macrophages in vitro, (3) the Mtb cell 
wall lipid, TDM, induces the formation of lipid-filled foam cells in mice in vivo, and 
(4) TDM-induced granulomas resemble the pathology of human TB granulomas.  
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CHAPTER ONE 
INTRODUCTION 
 
Mycobacterium tuberculosis and Tuberculosis 
  The causative agent of tuberculosis (TB), Mycobacterium tuberculosis (Mtb) 
bacillus, was first identified by Robert Koch in 1882 [1].  Mtb belongs to genus of 
Mycobacterium, family of Mycobacteriaceae, suborder of Corynebacterineae, order of 
Actinomycetales, and phylum of Actinobacteria.  A group of Mycobacterium species 
that can cause TB is called the Mtb complex, which includes Mtb, M. canettii, M. 
africanum subtype 1 M. pinnipedii, M. microti, M. bovis subsp. caprae, and M. bovis.  
Mtb complex members are known to have different host preferences; Mtb for humans, 
M. bovis for bovids, and M. pinnipedii for marine mammals [2-3].   
Mtb is reported to have around 4,000 putative genes, with 52% having known 
functions [4-5].  A large number of genes are involved in lipid metabolism and 
environmental regulation, which reflects the versatility of Mtb under extreme 
conditions [6-7].  Lipids in Mtb permit the characteristic acid-fastness and resistance 
to drying and antibiotics, and affect the host immune response [8-9].  Mtb is a slow 
grower, with replication time of 12~24 hours in vitro, and it is known to replicate 
much slower during acute or chronic infection in vivo [10-11].  TB transmission 
occurs when active TB patients cough up Mtb-containing aerosol droplets, which in 
turn are engulfed by phagocytes.  Mtb-containing phagocytes secrete various 
cytokines and chemokines, recruiting other leukocytes from the circulation to the site 
of infection.  This leads to the formation of TB granuloma, where Mtb bacilli reside.  
During the chronic infection, the granuloma protects not only the host from the 
bacterial transmission but also provides a shelter to Mtb.  When the disease becomes 
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active, Mtb bacilli replicate actively and escape from the localized TB granuloma, 
infecting other new hosts.   
TB is the second leading infectious cause of death worldwide, following 
acquired immune deficiency syndrome (AIDS), and it claims 2 million lives and 9 
million new individuals are infected with Mtb per year [12].  TB is more problematic 
in AIDS patients, whose immunity is severely compromised [13-15], and especially, 
sub-Saharan Africa is heavily afflicted by TB and human immunodeficiency virus 
(HIV) co-infection [15].  WHO has initiated the Directly Observed Therapy Short-
Course (DOTS) program in 1990 in Peru, and now worldwide, covering 62% of the 
world’s population [16-17].  DOTS has been very effective in improving treatment 
outcomes and preventing deaths and it is especially important in HIV care provision, 
because of the strong epidemiological link between TB and HIV and the high 
prevalence of HIV infection among TB patients.  The emergence of multidrug 
resistant TB (MDR-TB), extreme drug resistant TB (XDR-TB), and the poor 
socioeconomic conditions are another hurdle for reducing TB burden.    Expansion of 
DOTS program, early detection of TB, and novel strategies of reducing mortality from 
TB and TB-HIV co-infection are urgently needed to improve the global TB control.  
 
Treatment of Tuberculosis 
The available vaccine for TB prevention is an attenuated strain of M. bovis 
Bacille Calmette-Guérin (BCG).  BCG is administered to infants in more than 167 
countries and is effective in preventing TB in about 80% of children.  But its 
effectiveness is variable against TB in adults [18].  Modified BCG, attenuated Mtb, 
and protein or DNA subunit vaccines are actively being developed for TB prevention 
[19-21]. 
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  Treatment of TB with drug-susceptible Mtb requires at least 6-months of 
therapy with the first-line drugs: ethambutol, isoniazid, pyrazinamide, and rifampicin 
for 2 months, and then isoniazid and rifampicin for further 4 months.  MDR-TB 
treatment takes longer, at least 18 months.  Due to severe side-effects during the long 
regimen of antibiotic treatment, poor compliance of TB patients, and emergence of 
drug-resistant Mtb, it is necessary to develop novel therapeutics for TB treatment.  
One of the promising drugs is R207910 (TMC207, developed by Johnson & Johnson), 
diarylquinoline, an inhibitor of bacterial ATP synthase, that was very effective in TB 
treatment in mice, in combination with rifampicin and pyrazinamide [22-23].  
Linezolid and PNU-100480, oxazolidinone antibiotics that inhibit bacterial protein 
synthesis, is another promising agent against Mtb including drug-resistant strains [24-
26].  When administered with rifampicin and pyrazinamide, moxifloxacine was very 
effective in reducing Mtb burden by inhibiting DNA gyrase and topoisomerases [27].  
Inhibition of Mtb cell wall synthesis has been shown effective in treating TB.  SQ-
109, a novel diamine antibiotic, in combination with rifampicin, pyrazinamide, and 
isoniazid, improved the outcome of TB treatment [28].  Bicyclic nitroimidazoles such 
as PA-824 and OPC 67683 have proven to be effective against replicating and non-
replicating Mtb possibly by acting as nitric oxide (NO) donors and therefore 
augmenting the innate immunity-mediated killing mechanism [29-30].   
First described in the literature back in 18
th
 century, lung resection has been 
performed on patients with MDR-TB, complications of TB such as hemoptysis, 
bronchiectasis, or empyema, or difficult diagnosis between TB and cancer [31-36].  
Surgical cure rates of over 90% have been reported and the resection together with 
antibiotic treatment is important in treating TB patients lung resection is highly 
recommended to reduce the burden of infection. 
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Immunity to Tuberculosis 
A. Cytokines and Chemokines 
Mtb bacilli entering macrophage can block the phagosome maturation and the 
lysosomal fusion, therefore surviving within the phagocyte; but the host cell is not 
quiescent.  The host cells that phagocytose Mtb bacilli via various receptors such as 
complement receptor, mannose receptors, scavenger receptors, TLRs, and other 
unidentified receptors secrete various cytokines and chemokines.  In response to tumor 
necrosis factor (TNF)-α, chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-X-C 
motif) ligand (CXCL9), CXCL10, interleukin (IL)-1α, IL-1β, and IL-18, neutrophils 
are recruited and secrete more effector molecules such as TNF-α, CCL2, CCL3, 
CCL4, CCL5, CXCL9, and CXCL10 [37-38].  Successively, γδ T cells, natural killer 
T (NKT) cells, monocytes, and granulocytes arrive at the site of infection, followed by 
effector B and T cells.  Cluster of differentiation (CD) molecules, major 
histocompatibility complex (MHC) molecules, toll-like receptors, cytokines, and 
chemokines, implicated in TB pathogenesis are shown in Table 1.1 and 1.2.  
 
Tumor Necrosis Factor-α 
TNF-α is a primary mediator of immune regulation and the inflammatory 
response and has been implicated as a beneficial and harmful factor.  It is produced by 
numerous cells including monocytes, eosinophils, neutrophils, basophils, NKT cells, B 
cells, T cells, macrophages, granulosa cells, mast cells, Kupffer cells, astrocytes, 
osteoblasts, spermatogenic cells, retinal pigment epithelial cells fibroblasts, smooth 
muscle cells, glia, neurons, keratinocytes, and tumor cells.  TNF-α synthesis is tightly 
regulated so that it is rapidly synthesized and secreted in activated cells induced by 
infections.  TNF-α is critical in Mtb infection by stimulating neutrophils and 
macrophages in an autocrine and paracrine fashion to promote cell apoptosis and 
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Table 1.1 Cluster of Differentiation (CD) antigen, Major Histocompatibility Complex 
(MHC) molecule, and Toll-Like Receptor (TLR)  
 
CD antigen Leukocyte Function 
CD1a-e; MHC 
class I-like 
Dendritic cells, B cells, 
Langerhans cells, monocytes, 
activated T cells, some 
thymocytes, epithelial cells 
Display of non-peptide and glycolipid 
antigens for T-cell activation 
CD3 Thymocytes, T cells,       
natural killer (NK) cells 
Adhesion molecule involved in T-cell 
activation 
CD4 MHC class II-restricted T cells, 
some thymocytes, monocytes, 
macrophages, granulocytes 
Co-receptor for MHC class II-restricted 
T-cell activation; thymic differentiation 
marker for T cells; a receptor for HIV 
CD8 MHC class I-restricted T cells, 
thymocytes, subset of dendritic 
cells 
Co-receptor for MHC class I-restricted    
T cells 
DC-SIGN (dendritic-
cell-specific 
intercellular adhesion 
molecule-3-grabbing 
non-integrin); C-type 
lectin; CD209 
Dendritic cells Dendritic cell-mediated adhesion to 
endothelial cells and antigen endocytosis 
and degradation; binding to HIV 
MHC Cell type Function 
MHC class I All nucleated cells;     
composed of α-chain and       
β2-microglobulin 
Presents antigens to cytotoxic CD8
+
 T 
cells 
MHC class II antigen-presenting cells; 
dendritic cells, macrophages,   
B cells, epithelial cells, 
fibroblasts, thymic epithelial 
cells, thyroid epithelial cells, 
glial cells, pancreatic beta cells, 
vascular endothelial cells 
Presents antigens to helper CD4
+
 T cells 
Receptor Ligand Cell type 
TLR2 Lipopeptides, lipoproteins, 
glycolipids, lipoteichoic acid, 
heat-shock protein 70, zymosan 
Monocytes, macrophages,             
myeloid dendritic cells, mast cells 
TLR4 Lipopolysaccharide, heat- 
shock proteins, fibrinogen, 
heparan sulfate fragments, 
hyaluronic acid fragments 
Monocytes, macrophages,             
myeloid dendritic cells, mast cells, 
intestinal epithelium 
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Table 1.2 Cytokines and Chemokines  
 
Cytokine Sources Activity 
Interleukin-1 (IL-1),       
α & β 
Monocytes, macrophages, 
dendritic cells, B cells,    
T cells, NK cells, vascular 
epithelium, fibroblasts, 
some smooth muscle cells 
Induces fever and acute phase response; 
stimulates neutrophil production; 
regulates hematopoiesis; increases 
vascular permeability; promotes 
fibroblast proliferation; activates B cells 
and T cells; produces platelets 
IL-2; T cell growth factor T cells Stimulates growth and differentiation of 
B cells, T cells, and NK cells  
IL-4; B cell stimulating 
factor 1 
Mast cells, bone marrow 
stromal cells, T cells 
Promotes of growth and development of 
B cells, T cells, and monocytes; induces  
B-cell class switch to IgE; upregulates of 
MHC class II molecule 
IL-6; B cell stimulating 
factor 2; 
hybridoma/plasmacytoma 
growth factor; hepatocyte-
stimulating factor 
B cells, T cells, 
macrophages, bone 
marrow stromal cells, 
fibroblasts, endothelial 
cells, astrocytes 
Induces fever and acute phase response; 
regulates B cells and T cells; regulates 
hematopoiesis; increases vascular 
permeability; produces platelets; 
increases immunoglobulin synthesis 
IL-10; cytokine synthesis 
inhibitor 
Activated subset of   
CD4
+
 and CD8
+
 T cells 
Stimulates proliferation of B cells, mast 
cells, and thymocytes together with 
transforming growth factor-β; stimulates 
IgA synthesis and secretion by B cells; 
antagonizes generation of TH1 cells 
IL-12; NK cells stimulatory 
factor; Cytotoxic lymphocyte 
maturation factor 
Dendritic cells, 
macrophages 
Induces differentiation of TH1 cells; 
induces interferon gamma production by 
T cells and NK cells; enhances NK-cell 
activity 
IL-18; interferon gamma-
inducing factor 
Monocytic cells, dendritic 
cells 
Promotes TH1 differentiation; induces 
interferon gamma production of T cells; 
enhances NK-cell cytotoxicity 
Interferon gamma; 
macrophage-activating factor; 
T-cell interferon 
CD4
+
 and CD8
+
 T cells, 
NK cells 
Promotes leukocyte adhesion; induces 
activation, growth, and differentiation of 
macrophages, B cells, T cells, and        
NK cells; upregulates MHC expression 
on antigen-presenting cells; promotes 
TH1 cell differentiation 
Transforming growth 
factor beta; 
differentiation-inhibiting 
factor 
Many nucleated cell types 
and also found in platelets 
Affects tissue remodeling, wound repair, 
development, and hematopoiesis; induces 
B-cell class switch to IgA; induces cell 
apoptosis; promotes CD25
+
 regulatory T 
cells 
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Table 1.2 (Continued)  
 
Cytokine/Chemokine Sources Activity 
Tumor necrosis 
factor alpha; cachectin; 
TNF ligand superfamily 
member 2 
Monocytes, macrophages, 
neutrophils, fibroblasts, 
activated T cells, NK cells 
Induces fever and acute phase response; 
cytotoxic to transformed cells;     
promotes angiogenesis, bone resorption, 
and thrombotic processes;         
suppresses lipogenetic metabolism;          
a potent chemoattractant for neutrophils; 
stimulates macrophages; increases insulin 
resistance  
Chemokine (C-C 
motif) ligand 2; 
monocytes chemotactic 
protein-1 
Produced by tumor cells and 
a variety of cell types; 
inducible by oxidative 
stress, cytokines, or growth 
factors 
Recruits monocytes, dendritic cells, and 
memory T cells to the site of tissue injury 
and infection; promotes osteoclast 
differentiation; causes degranulation of 
mast cells and eosinophils   
CCL3 & 4;   
macrophage inflammatory 
protein-1 α & β 
Inducible in most 
hematopoietic cells; 
monocytes, macrophages, 
neutrophils, B cells, T cells, 
dendritic cells, mast cells, 
NK cells, platelets, 
osteoblasts, astrocytes, 
microglia, epithelial cells, 
fibroblasts   
Activates granulocytes leading to acute 
neutrophilic inflammation; induces 
synthesis and secretion of IL-1, IL-6, and 
TNF-α; recruits T cells, NK cells, 
monocytes, and many other immune 
cells; HIV suppressive factor; implicated 
in many diseases including arthritis, 
multiple sclerosis, granuloma formation, 
asthma, sepsis, and myeloid leukemia 
CCL5; regulated upon 
activation, normal T-cell 
expressed, and secreted 
(RANTES) 
Many cell types including 
monocytes, macrophages,   
T cells, fibroblasts, renal 
and pulmonary epithelium, 
endothelium, and airway 
smooth muscle 
Recruits T cells, eosinophils, basophils to 
the inflammatory site; induces 
proliferation and activation of NK cells; 
causes the release of histamine from 
basophils and activated eosinophils 
Chemokine (C-X-C 
motif) ligand 9 
Dendritic cells, B cells, 
macrophages,       
endothelial cells 
Recruits T cells NK cells to the 
inflammatory site; suppresses tumor 
growth 
CXCL10; 10 kDa 
interferon gamma induced 
protein 
Monocytes, endothelial 
cells, fibroblasts 
Recruits monocytes, macrophages,          
T cells, NK cells, and dendritic cells; 
promotes T-cell adhesion to the 
endothelium;  inhibits tumor growth, 
bone marrow colony formation, and 
angiogenesis   
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reactive oxygen and nitrogen intermediate production [39-42].    It also organizes the 
formation of TB granuloma, as manifested by TB reactivation in individuals who 
receive anti-TNFα therapy [37, 43-44].  On the other hand, uncontrolled synthesis of 
TNF-α is responsible for fever, wasting, and lung pathology in TB patients [43, 45].  
In the presence of mycobacterial infection, TNF-α upregulates the production of 
matrix metalloproteinases and urokinase, and thereby leads to the destruction of the 
structural components of the lung [45-47]. 
 
Interferon-γ 
Interferon-γ (IFN-γ), produced by CD4+ T cells, CD8+ T cells, and NKT cells, 
activates infected macrophages to overcome the mycobacterial inhibition of 
phagosomal maturation and to destroy the pathogen.  The importance of IFN-γ in 
granuloma formation, downregulation of proinflammatory response and macrophage 
activation has been described using the murine model [48-49].  Although both CD4
+
 
and CD8
+
 T cells are crucial for the effective control of Mtb, TH1-polarized CD4
+ 
T 
cells seem to be more important in controlling TB, by secreting IFN-γ [38, 48-50].   
 
Interleukins 
  A member of IL-1 family, IL-1β, is produced by macrophages, dendritic cells 
(DCs), monocytes, and fibroblasts, and nearly all microbes and microbial products 
induce production of IL-β.  It plays an important role in anti-mycobacterial response 
and is implicated in disease severity and fever in TB patients [51-53].  IL-6 is 
produced by both lymphoid and non-lymphoid cells and regulates immune response, 
acute-phase reactions, and haematopoiesis [54].  A high level of IL-6 was detected in 
pleural effusion in TB patients, and bronchoalveolar lavage cells from TB patients 
released significantly increased amounts of IL-6 together with IL-1β and TNF-α [55-
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57].  Unlike IL-1, IL-6, or TNF-α, the secretion of IL-4 is restricted to certain cell 
types: activated T cells, mast cells, and basophils.  IL-4, a TH2 cytokine, appears to 
exacerbate the tissue damage by synergizing with TNF-α, and IL-4 was observed in 
lavage fluid and peripheral blood samples from patients with cavitary TB [58].        
 
B. Innate Immune Cells 
Innate immune cells are capable of recognizing and responding to microbes 
and mediate the appropriate initiation of the acquired immunity, which in turn 
activates phagocytes to eliminate the infection.  Phagocytes are critical in wound 
healing, inflammation, and host defense; professional phagocytes include 
macrophages, monocytes, and neutrophils, and DCs are considered paraprofessional 
phagocytes.   
 
Dendritic cells 
Immature DCs of myeloid lineage are able to phagocytose microbes and 
process antigens, and then they become mature, presenting antigens to naïve T cells.  
The roles of DCs in Mtb infection are still under investigations.  DCs are known to 
phagocytose Mtb via a specialized C-type lectin known as DC-specific intercellular 
adhesion molecule-3-grabbing non-integrin (DC-SIGN) [59-61].  Specifically, the 
mycobacterial cell wall component, mannose-capped lipoarabinomannan (ManLAM), 
was demonstrated to bind to DC-SIGN, which resulted in the production of anti-
inflammatory cytokine, IL-10, and it was proposed that Mtb infection downregulates 
DC-mediated immunity [59, 62].  However, these data are in contrast to the 
observation made by Schaefer et al. that DC-SIGN may promote protection by 
limiting Mtb-induced pathology [63].  
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Macrophages                                                                                                                                         
Originated from blood monocytes, macrophages are distributed throughout all 
tissues and important as a first line defense against infection [64].  Macrophages are 
involved in both innate and acquired immunity; detect microbial invasion, restrict 
microbial spread by phagocytosis and killing, recruit immune cells by releasing 
cytokines and inflammatory mediators, activate lymphocytes by presenting antigens 
and producing cytokines, kill microbes by cell-mediated immunity, and participate in 
humoral immunity by binding antibodies and complements.  Macrophages are also 
important in resolving the inflammation by producing anti-inflammatory factors 
including IL-10 and transforming growth factor β (TGF-β).  Macrophages also serve 
as a niche for many pathogens including Mtb.   Mtb bacilli are recognized by pattern 
recognition receptors (PRRs) such as complement receptors (CRs), mannose receptor 
(MR), CD14, and surfactant protein A receptor [65].  The microbes within 
phagosomes are killed by low pH and lysosomal fusion, limitation of nutrients, and 
the generation of reactive oxygen and nitrogen intermediates; however, Mtb has the 
ability to arrest phagosomal maturation [66].  Many studies have been done to 
understand how Mtb interferes with endocytic pathway, thereby evading the host 
immune response.  The Mtb cell wall lipid, ManLAM, has been shown to be able to 
block the recruitment of Rab5A effectors, early endosome antigen 1 protein (EEA1) 
and phosphatidylinositol-3-OH-kinase (hVPS34) [67-69].  Mtb also produces a 
phosphatase, SapM, which hydrolyzes phosphatidylinositol-3-phosphate, inhibiting 
the fusion of phagosome and late-endosome [70], and it is resistant to the acidification 
of phagosome, by excluding the vesicular proton ATPase [71].  The confined 
environment of Mtb-phagosome have limited nutrients, however, Mtb can obtain iron 
by binding iron with a higher affinity than the host molecule [72].  Moreover, 
polymorphisms in natural resistance-associated macrophage protein 1 (Nramp-1) 
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which is thought to play a role in the removal of iron from the phagosome are 
significantly associated with TB [73].  The macrophage respiratory burst producing 
reactive oxygen intermediates is one of Mtb-killing mechanism, and mice lacking 
nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) were shown 
to have increased numbers of Mtb bacilli during the early infection [74].  Reactive 
nitrogen intermediates generated in phagocytes are also effective in killing microbes; 
transposon mutants screening revealed that Mtb proteasome confers the resistance to 
oxidative or nitrosative stress [75].  Mtb is also shown to downregulate the surface 
expression of CD1, inhibiting T cell activation [76].   
 
C. Acquired immune cells 
The innate immune response against microbial infection is followed by 
acquired immune response, which is initiated by the recognition of foreign antigens.  
The antigen-specific response is divided into cell-mediated immunity of T cell 
activation and effector mechanism and humoral response of B cell maturation and 
antibody production.   
 
B cells 
The role of humoral response in TB pathogenesis is still unclear.  It was shown 
that the absence of humoral response does not change the course of Mtb infection in 
mice [77-78].  However, a recent study in B cell deficient mice infected with Mtb 
showed increased recruitment of pulmonary neutrophils, exacerbated lung pathology, 
elevated production of IL-10, and uncontrolled bacterial growth [79].  Furthermore, 
lymphoid-like B cell aggregates were found in proximity to granulomas in mice and 
human, emphasizing the involvement of B cells in modulating the inflammatory 
response during TB infection [79-83].                  
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CD4
+
 T cells 
            MHC class II-restricted CD4
+
 T cells are required to form TB granulomas and 
to produce IL-2, IL-12, IFN-γ, and TNF-α [84].  Patients with severe pulmonary TB 
showed higher percentage of CD4
+
 T cells and increased ratios of CD4
+
/CD8
+
 in 
bronchoalveolar lavage fluid but not in peripheral blood [85].  CD4
+
 T cells have been 
shown to be required for the resistance to Mtb infection in mice; especially IFN-γ and 
nitric oxide synthase 2 induced by CD4
+
 T cells were critical in the early 
immunological response and granuloma formation [86].   Another example of the 
importance of CD4
+
 T cells is that HIV/AIDS patients who have low CD4
+
 counts are 
more susceptible to TB progression and TB is responsible for the major cause of death 
in TB/AIDS patients.   
 
CD8
+ 
T cells 
            The development of most of CD8
+
 T cells requires the recognition of antigenic 
peptides in the context of MHC class Ia molecule complexed with β2-microglobulin 
(β2m).  Experiments using mice deficient in transporter associated with antigen 
processing (TAP), CD8
+
 T cells, or MHC class Ia heavy chain showed that CD8
+
 T 
cells are protective against TB [87-89].  CD8
+
 T cells specific for Mtb antigens are 
able to produce IFN-γ and TNF-α [90].  IFN-γ plays a key role in protection to Mtb 
infection and in activation of macrophages to produce reactive nitrogen intermediates 
and to kill intracellular Mtb.  In addition to cytokines, CD8
+
 T cells are also equipped 
with a pore forming protein, perforin, in the cytotoxic granules, which lyses infected 
macrophages [91-93].  Perforin was shown to be critical in regulating TB in mice [94].  
CD8
+ 
T cells also produce TNF-α, which is a key molecule for macrophage activation 
and granuloma formation and maintenance.  In TB patients, the number of IFN-γ 
producing CD8
+
 T cells is decreased whereas the number of IL-4 producing CD8
+
 T 
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cells is increased [95].  Even though memory CD8
+
 T cells were observed in the 
murine lungs infected with Mtb, the overall levels of CD8
+
 T cells responding to the 
secondary Mtb infection were not high [96].   
 
CD1-restricted T cells 
The unconventional MHC Ib and CD1-restrcted T cells also play a role in Mtb 
infection.  CD1 molecule is associated with β2 on the cell surface and its heavy chain 
is composed of three domains that accommodate lipid tails of glycolipids [97-98].  
There are five forms of CD1 in humans, CD1a, CD1b, CD1c, CD1d, and CD1e, and 
mice have CD1e.  Mtb has a thick cell wall mainly composed of glycolipids, which are 
known to be presented to T cells by CD1 [99].  Free and monoglycosylated mycolic 
acids, lipoarabinomannan (LAM), phosphatidyl-myo-inositol mannosides (PIMs), and 
diacylated sulfoglycolipids are presented by CD1b or CD1d [100-102].  Moreover, the 
presentation of LAM by CD1b is shown to require saposin C (SapC), which transfers 
lipid antigens from the intralysosomal membranes to CD1b [103]. 
 
Tuberculous Granuloma 
Mtb-containing aerosols expectorated from open cavitary TB granuloma are 
inhaled by a new host, and Mtb bacilli travel through the respiratory tract and are 
implanted mostly near the pleura.  Mtb is mainly phagocytosed by the front line 
immune cells such as alveolar macrophages, neutrophils, and sometimes DC, but type 
II lung epithelial cells are also known to harbor Mtb [104-105].  One single Mtb 
bacillus is known to be sufficient for successful infection [106].  Infected macrophages 
are activated through toll-like receptor 2 (TLR2) and TLR4 and rapidly secrete pro- 
and anti-inflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-10, and IL-12, and 
recruit macrophages, monocytes, neutrophils, B cells, NKT cells, CD4
+
 T cells, and 
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CD8
+
 T cells [107-110].  These cells secrete additional cytokines and chemokines to 
recruit more leukocytes to the site of infection [39-40, 82, 111].  This response leads 
to the establishment of an early granuloma.  Mtb bacilli are also drained into the 
regional lymph nodes presumably by DC.  Typically, in response to Mtb infection, a 
well-organized granuloma develops; infected macrophages are surrounded by 
epithelioid cells (activated macrophages, commonly seen in granulomatous response), 
foam cells, foreign-body giant cells, and Langhans giant cells (formed by the fusion of 
epithelioid cells), which become encircled by lymphocytes and fibroblasts that form a 
tight fibrous capsule (Figure 1.1).  If the granuloma progresses, it undergoes caseation 
(Figure 1.1).  This primary site of Mtb infection is called Ghon focus, and together 
with the inflamed regional lymph nodes is known as Ghon complex.  
Immunocompetent adults can control Mtb infection by forming a tightly structured 
granuloma or resolve the lesion completely, whereas infants, children, elders, 
immunocompromised individuals are more prone to the development of disseminated 
and extrapulmonary TB [112-113].  Typically, about 10% of Mtb-infected individuals 
develop active TB disease; primary TB starts in the lung and spreads hematogenously 
to the body, whereas secondary (or post-primary) TB develops in individuals who 
already have developed immunity against the primary infection.  Primary TB shows 
subtle clinical symptoms, whereas secondary TB is accompanied by symptoms such as 
fever, anorexia, dyspnea, hemoptysis, empyema, bronchiectasis, night sweats, and 
weight loss.  Secondary TB is also characterized by liquefaction of caseum and 
cavitation of granuloma.   
 
Foamy Macrophages in Tuberculous Granuloma 
The chronic inflammatory response to Mtb infection leads to the formation of a 
granuloma in which mononuclear phagocytes are predominant; macrophages, 
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Figure 1.1 Human tuberculous granuloma 
Mtb-infected macrophages are surrounded by various leukocytes including monocytes, 
lymphocytes, and macrophages.  Multinucleated giant cells, lipid-filled foamy 
macrophages, and epithelioid cells are frequently seen in TB granulomas.  The 
granuloma containing caseum is demarcated by a ring of fibrous capsule.   
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epithelioid cells, multinucleated giant cells, and foamy macrophages (foam cells).  
Adipocytes and steroidogenic cells are classical lipid droplets-containing cells, but all 
cell types including neutrophils and macrophages have the potential to develop lipid 
droplets under the condition of elevated fatty acid levels [114].  Unlike classical 
lipids-storing cells, leukocytes contain few lipid droplets under normal conditions; 
human neutrophils and eosinophils are known to contain 1 to 5 lipid droplets per cell, 
and the number increases dramatically in inflammatory response [115-116].  The 
number of lipid droplets in leukocytes increases in conditions such as atherosclerosis, 
obesity, sepsis, infectious diseases, and type II diabetes.  Studies have shown that lipid 
droplet formation in leukocytes is highly regulated and this process is cell- and 
stimuli-dependent; unsaturated fatty acids induce lipid droplet formation in 
neutrophils, monocytes, eosinophils, and macrophages [117-118]; modified low 
density lipoprotein (e.g. acetylated-, oxidized-LDL), leptin, and CCL2 affect 
macrophages [119-122]; lipopolysaccharide and mycobacterial LAM stimulate 
neutrophils and macrophages [123-124].  Lipid droplets in leukocytes are also known 
to be major sites for eicosanoid (e.g. leukotriene C4 and prostaglandin E2) generation 
[120, 124-129], cytokine (e.g. TNF-α) storage [130], and compartmentalization of cell 
signaling molecules (e.g. mitogen-activated protein (MAP) kinases) [127].               
 
Mycobacterial Cell Wall 
             Mtb has a unique cell wall structure [9, 131-132].  Studies have shown that 
Mtb is protected by a highly lipophilic barrier, consisting of lipids up to 60% of the 
dry weight of the bacillus [8, 133].  Mycolic acids are intercalated to arabinogalactan,  
which is linked to peptidoglycan connected with cell membrane (Figure 1.2) [131].  
Phthiocerol dimycoserosates, phenolic glycolipids, trehalose-containing glycolipids, 
and sulfolipids are known to be arrayed freely in the outer membrane, and PIMs,  
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Figure 1.2 Structure of mycobacterial cell wall 
Brennan PJ and Crick DC (2007) Curr. Top. Med. Chem. 7: 475–488 
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LAM, and lipomannan are anchored to the plasma membrane through phosphatidyl-
myo-inositol anchor.  Many of these lipids show potent biological activities and are 
considered virulence factors.   
              Mycolic acids (mycolates) from Mtb are long-chain high molecular weight α-
alkyl β-hydroxy fatty acids consisting of a meromycolate moiety, with carbon chain 
lengths of up to C56 and a long saturated α-branch, C20 to C24.  Mycolates give rise to 
important characteristics of Mtb such as resistance to chemical injury, resistance to 
dehydration, low permeability to hydrophobic antibiotics, and the ability to persist 
within the host cells [134].  Mycolates are divided into α-mycolates and oxygenated 
mycolates; α-mycolates do not contain oxygen functionality and oxygenated 
mycolates include keto- and methoxymycolates containing cis- and trans-
cyclopropane rings.  Cyclopropanation of mycolates has been demonstrated to 
suppress Mtb-induced inflammation and virulence and to be essential for viability, 
drug resistance, and cell wall integrity of Mtb [135-136].   
             Trehalose-6,6'-dimycolates (TDM), also known as cord factor, is the most 
extensively studied mycolate.  Even though TDM represents a small percentage of the 
total mycolates, this petroleum ether-extractable glycolipid is an extremely potent 
modulator of the proinflammatory response.  Lung cells from mice treated with TDM 
were shown to secrete IL-4, IL-6, IL-10, and TNF-α, and bronchoalveolar lavage cells 
produced NO, and peritoneal macrophages treated with TDM in vitro also produced 
IL-6, IL-10, IL-12, IFN-γ, and TNF-α [137].  TDM also elicits the production of 
chemokines, monocytes chemoattractant protein 1 (MCP-1), macrophage 
inflammatory protein 1α (MIP-1α) [138-139].  The granulomatous response of TDM 
is also associated with the increased pro-coagulant activity and the decreased level of 
serum cortisol [140-146], and with the secretion of vascular endothelial growth factor 
(VEGF) from neutrophils and macrophages [147].  
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TDM exhibits toxicity in cells, disrupting mitochondrial respiratory chain and 
oxidative phosphorylation [148-149] and has been shown to have anti-tumor activity 
most likely via TNF-α, NO, and NK cells, hence clinicians have used TDM for 
treating cancers such as colon cancer, melanoma, small lung cancer, prostate cancer, 
and astrocytoma [150-151].  TDM also induces apoptosis, cytotoxicity, cachexia, and 
death in mice [152-154].    
 
Models for Tuberculosis Research 
             The limited availability of human TB tissue samples poses an obstacle for 
detailed study of the disease.  Mice, guinea pigs, rabbits, and nonhuman primates are 
commonly used as models of TB [111, 155-158].  Since TB transmission mainly 
occurs in secondary TB, guinea pigs which develop both primary and secondary TB 
lesions provide a unique system for the evaluation of vaccine and chemotherapeutic 
candidates [159].  Granulomas in rabbits liquefy and cavitate, resembling human TB 
granulomas [155, 160].  The major drawbacks of guinea pig and rabbit models are the 
high expense and the limitation of reagents.  Monkey TB shows very similar lung 
pathology to human TB; caseation, liquefaction, cavitation, fibrosis, and calcification 
of granulomas [156].  However, the cost of monkeys in research is very high and bio-
containment is another hurdle.   Mice have been used for TB research most 
extensively, but they do not show similar pathologies and bacterial growth to human 
infection; absence of true latent infection, differences in granuloma structure, and lack 
of certain molecules including leukocyte defensins, TLR10 (pseudogene), CD1a, 
CD1b, CD1c, FcαRI, FcγRIIA, caspase 10, and intercellular adhesion molecule 3 
(ICAM3)  [157-158, 161-169].  Another attractive model is zebrafish, Danio rerio, 
which is a natural host for M. marinum infection [170-171].  There are several 
remarkable similarities between M. marinum and Mtb such as genetic makeup, cell 
 20 
 
wall synthesis, granuloma formation, and secretion.  Furthermore, the absence of 
acquired immunity in zebrafish embryos allows examining innate and acquired 
immunities separately in mycobacterial pathogenesis.  
 
Murine Granuloma Model 
             Work done in Dr. David Russell’s laboratory showed that mycobacterial cell 
wall lipids were trafficked out of mycobacteria-containing phagosomes and could be 
transferred to bystander cells [69, 172].  Further studies identified the released lipid 
species and determined the bioactivities of individual lipid by using a granuloma 
model developed by the Russell laboratory [173-175].  In this model, each lipid 
species is coated onto the surface of 90 µm-diameter polystyrene microspheres, mixed 
with syngeneic macrophages, suspended in growth factor-reduced Matrigel, and then 
injected into the peritoneal cavity of mice [175].  The injected macrophages 
phagocytose lipids off the microspheres and secrete cytokines and chemokines to 
initiate the immune response.  Matrigel (BD) is a mixture of extracellular matrix 
proteins from Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells, mimicking the 
complex extracellular environment of tissues.  As Matrigel is solidified at body 
temperature, the mixture of Matrigel with mycobacterial lipids forms a mass that can 
be easily removed for analyzing cell recruitment, cytokine production, and 
histopathology.  Our study has shown that TDM is the most inflammatory and 
granulomatous species among mycobacterial cell wall lipids [174].  In the current 
study (Chapter 6), the granuloma model is used with slight modifications; Matrigel 
mixture is prepared without syngeneic macrophages and injected subcutaneously. 
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Aims of this study 
The purpose of the following work is to understand the biology of tuberculous 
granuloma.  Chapter 2 presents data that delineate the transcriptional profiles of 
caseous human pulmonary TB granulomas.  Three genes involved in lipid metabolism 
(ADFP, ACSL1, and PSAP (SapC)) were selected for further analysis.  Chapter 3 
examines the localization of ADFP, ACSL1, and SapC in human TB granulomas.  
Chapter 4 analyzes the lipid composition of the caseum from human TB granulomas.  
Chapter 5 investigates the macrophage response to Mycobacterium tuberculosis 
infection in vitro.  By using the murine granuloma model, Chapter 6 explores the in 
vivo response to mycobacterial cell wall lipid, trehalose dimycolate, which is 
reminiscent of human TB.       
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CHAPTER TWO 
TRANSCRIPTIONAL PROFILING OF HUMAN PULMONARY 
TUBERCULOUS GRANULOMAS 
 
ABSTRACT 
The macrophages infected with Mycobacterium tuberculosis (Mtb) secrete various 
cytokines and chemokines that recruit other leukocytes to the site of infection.  This 
leads to the formation of tuberculous (TB) granulomas, a hallmark of TB, at the local 
foci.  Surrounded by immunological cells and their effectors, Mtb cannot easily escape 
the well-stratified granuloma.  Immunocompetent people infected with Mtb can 
maintain this granuloma structure, thereby controlling the infection.  However, in 
immunecompromised people, the center of TB granuloma caseates extensively, 
liquefies, and erodes into the airway space, transmitting numerous Mtb bacilli to new 
hosts.  The mechanism for the development of dormant TB granulomas into active 
lesions is not well-understood yet.  In this study, we demonstrate genome-wide 
transcriptional profiles of caseous human pulmonary TB granulomas compared to 
human normal lung tissues, by using laser capture microdissection (LCM) to select TB 
granulomas only, excluding uninvolved areas.  This technique is also applied to select 
for normal lung parenchyma.  The amplified messenger RNAs from dissected 
segments are used for genome-wide microarray.  This is the first description of 
transcriptional profiles for human pulmonary TB granulomas and provides invaluable 
tools for further investigation of TB pathogenesis.      
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INTRODUCION 
Granulomatous diseases occurring in the lung can be divided into caseating, 
non-caseating, and the diseases are categorized into infectious or non-infectious.  
Infectious ones include tuberculosis (TB), histoplasmosis, cryptococcosis, and 
blastomycosis, whereas sarcoidosis, berylliosis, Wegener’s granulomatosis, Churg-
Strauss disease, and aspiration pneumonia belong to non-infectious granulomatous 
diseases [1].  The term caseation derives from the gross cheesy appearance of TB 
granuloma.  Mycobacterium tuberculosis (Mtb) infection results in the formation of 
TB granuloma, a collection of immune cells.  Most immunocompetent people confine 
the infectious bacilli inside the TB granulomas or completely resolve the infection 
foci.  However, some TB granulomas develop a caseating center, caseation, or 
caseum.  The caseum of TB granuloma may liquefy and cavitate.  At this stage, it is 
believed that Mtb bacilli multiply exponentially and are released into the open airways 
via the cavitated granulomas.  The formation of caseum in TB granuloma is 
histologically manifest in TB patients with an active disease; however, it is still 
unclear how TB granulomas acquire a caseous center and ultimately liquefy and 
cavitate at the late stage of the disease.  Despite the importance of TB granulomas in 
TB pathogenesis, gene regulation of human TB granulomas is not well-characterized. 
In the past years, microarray analysis has been employed in many research 
areas to understand gene regulation [2].  There are a few reports of gene expression 
profiles from bronchial alveolar lavage fluid (BALF) samples, peripheral blood 
mononuclear cells (PBMCs) or human cell lines in response to Mtb infection, using 
real-time quantitative RT-PCR and/or microarray for a subset of genes [3-6].  
Although these previous studies provide us valuable information, we feel that the 
characterization of global gene expression will provide an indispensable understanding 
of TB pathogenesis. 
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In this study, we examined the transcriptional profiles of caseous human 
pulmonary TB granulomas.  Since the granuloma is an isolated structure, it is prudent 
to analyze the granulomas only, thereby excluding uninvolved lung tissues.   Chan and 
colleagues [7] performed laser capture microdissection (LCM) on murine pulmonary 
TB granulomas and compared gene expression from LCM samples with that from 
whole lung tissues by real-time quantitative RT-PCR.  Their data demonstrated that 
the true gene expression profile of affected lung lesions was diluted by introducing 
unaffected lung parts to the analysis; therefore LCM technique is useful to procure 
more homogeneous populations of cells from defined regions of tissues for examining 
the transcriptional profiles [7-8].  The successful microarray analyses on human 
pulmonary TB granulomas are presented here.     
                   
MATERIALS and METHODS 
Human Subjects  
Human subjects were included in this study according to protocols approved by 
Institutional Review Boards at University of Cape Town, South Africa, the Public 
Health Research Institute, Newark, NJ, and Cornell University, Ithaca, NY.  Informed 
consent was obtained from all of patients.   
 
Tissue specimens  
We have obtained human TB lung tissue specimens which were surgically excised 
when TB patients had extensive lung cavitation and tissue degeneration, with no 
response to the antibiotics.  The TB patients in our study did not have human 
immunodeficiency virus (HIV) infection or acquired immune deficiency syndrome 
(AIDS) at the time of surgery.  Snap-frozen tissues were transported from Groote 
Schuur Hospital of Cape Town to PHRI, and then transferred to our biosafety level-3 
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(BL3) laboratory.  Frozen samples were embedded in O.C.T. compound (Tissue-
Tek®), cut into 10 µm-thick sections at −25°C on a Cryocut 1800 cryostat (Leica 
Microsystems) and attached onto PET-membrane frame slides (Leica Microsystems) 
for laser capture microdissection or Superfrost Plus Micro slides (Erie Scientific) for 
histological examination.    
 
Histological examination  
Cryosections are fixed in 1% paraformaldehyde in PBS for 40 min, which has been 
proven to kill Mtb.  After washing in water, sections are stained with hematoxylin and 
eosin, dehydrated, cleared, and mounted with Permount® (Fisher Scientific).  Areas of 
interest were microscopically matched to the unstained sections on the PET-membrane 
frame slides for LCM.   
 
Laser Capture Microdissection 
Tissue sections mounted onto PET-membrane slides were fixed in graded ethanol 
(70%, 75%, 96%, and 100%) containing 0.5% sodium azide for 30 sec per each step.  
Slides were air dried briefly and stored at −80°C until further processing.  Areas of 
interest were dissected by using Leica AS LMD system (Leica Microsystems), and the 
dissected samples were collected in RNase free 0.5 ml tubes (Eppendorf) by gravity 
and placed on dry ice until processing.   
 
RNA Isolation from LCM samples 
Successful RNA isolation from LCM samples has been documented in multiple 
publications [7-12].  Using the PicoPure
TM
 RNA Isolation Kit (Arcturus), total RNA is 
extracted from LCM-derived materials by incubating in extraction buffer at 42°C for 
30 min.  Subsequently, RNA is isolated following the manufacturer protocol, coupled 
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with DNase treatment using TURBO DNA-free
TM
 (Ambion).  Purity, quality, and 
quantity of RNA are assessed by the Agilent NanoChip Bioanalyzer assay, 
spectrophotometer, and reverse-transcription PCR (RT-PCR) for β-actin (234 bp), 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 189 bp), 18S rRNA (236 bp), 
and ubiquitin (198 bp).   
 
Two-round linear amplification and biotin-Labeling of RNA  
The reproducibility and validity of RNA amplification methods allow microarray 
analysis from a limited amount of RNA [9, 11-12].  To obtain sufficient quantities of 
biotin-labeled RNA for hybridization onto microarray, two-rounds of linear 
amplification of RNA were conducted, using RiboAmp HS
TM
 RNA Amplification Kit 
(Arcturus).  Briefly, using a T7-Oligo (dT) primer, a T7 promoter was incorporated 
during the conversion of 10-20 ng of total cellular RNA into double-stranded cDNA.  
Double-stranded cDNA was then transcribed in vitro by T7 RNA polymerase to 
generate multiple antisense RNA (aRNA) copies in the sample.  Next, a second round 
of linear amplification was performed using aRNA from the first round as the template 
for cDNA synthesis.  Finally, using the BioArray High Yield
TM
 RNA Transcript 
Labeling Kit (T7) (Enzo Life Sciences, Inc.), biotin-labeled ribonucleotides were 
incorporated into aRNA during the second in vitro transcription (IVT) reaction.  Two-
rounds of linear amplification from 10-20 ng of total RNA yielded up to 10-20 μg of 
biotinylated target.  The quality and quantity of the amplified aRNA were checked by 
using spectrophotometer and Agilent NanoChip Bioanalyzer. 
 
Hybridization and scanning 
Fifteen microgram of biotin-labeled aRNA was fragmented and the quality and 
quantity of the fragmented aRNA were checked by using spectrophotometer and 
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Agilent NanoChip Bioanalyzer.  Fragmented aRNA was hybridized onto GeneChip® 
Human X3P Array (Affymetrix) for 16 hours at 45°C at Cornell Microarray Core 
Facility.  Genechips were washed and stained in Affymetrix Fluidics Station FS450 
and scanned using Affymetrix GeneChip Scanner 3000 7G at Cornell Microarray Core 
Facility.   
 
Microarray Data analysis 
We performed three independent arrays on the LCM-derived granuloma sample from 
one patient, which confirmed the reliability of the technique.  Thereafter, two other 
granuloma samples from two patients were further analyzed by microarray for 
biological replicates.   
For the generation of a hierarchical list of absolute gene expression profile in caseous 
human pulmonary TB granulomas, raw CEL files were analyzed at the probe level 
using R and Bioconductor.  Only PM probes were included in the estimation for 
expression level of probe sets.  Raw PM intensities from each array were subjected to 
local background correction using MAS5 method, log2-transformed and median-
centered.  Informative PM probes from each probe set were selected as having the 
highest mean across all arrays.  In this study, the mean signal of top 5 informative PM 
probes of each probe set was used to represent its expression level.   
The data for caseous granulomas and normal lung parenchyma were analyzed using 
GeneSpring GX 10.0.2 program (Agilent).  MAS5 method was used to summarize raw 
CHP files.  Normalization was done by scaling to median of all samples and the 
baseline was transformed to the median of all samples.  List of genes differentially 
expressed between caseous human pulmonary TB granulomas and normal lung 
parenchyma was generated.   
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The networks between gene products were generated by using Ingenuity Pathway 
Analysis (Ingenuity® Systems, www.ingenuity.com).   
 
Statistical analysis 
The statistical significance of differences in gene expressions between normal human 
lung tissues and caseous human pulmonary TB granulomas was calculated using an 
unpaired t test with Benjamini-Hochberg correction.  Results with a P value less than 
0.05 were considered significant. 
 
RESULTS and DISCUSSION 
In an effort to understand how the host responds to Mtb infection, we 
examined the regulation of genes in human pulmonary TB granulomas.  Depending on 
the stage of the granuloma development, TB granulomas differ histologically.  For this 
study, we specifically selected caseous granulomas because caseous granulomas 
represent a histologically-defined structure that is used as a diagnostic marker of 
progression to active disease, bacillary growth and transmission.  The cryosection of 
human TB lung tissues shows a chromogenic area, which corresponds to the caseous 
granuloma (Figure 2.1).  Each cryosection from TB lung tissues was fixed and 
immediately processed for LCM.  Since tissues from TB patients were degenerate due 
to the extreme disease state, therefore, RNA isolation from LCM-derived samples was 
technically challenging.  PicoPure
TM
 RNA Isolation Kit and RiboAmp HS
TM
 RNA 
Amplification Kit allowed the successful isolation and amplification of RNA from 
such tissue samples and generated sufficient RNA for microarray analysis.  In the 
current study, tissue samples from three TB patients were used for biological 
replicates, and one of the three samples was used as a technical replicate.  Even though 
the uninvolved lung tissues in our archive looked histologically normal, RNA of  
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Figure 2.1 Cryosection of caseous human pulmonary TB granuloma (circled) appears 
chromogenic indicating the abundance of lipid. ×4   
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quality good enough for microarray was generated from only one sample.  The paucity 
of intact RNA may be due to the low number of cells present in normal lung tissues. 
The parenchyma of control lung tissue was processed as TB granulomas, and the 
sample was technically replicated.   
The normal tissues are typically used as a control for diseased tissues.  
However, the cell lineage of TB granulomas is strikingly different when compared to 
normal lung parenchyma; thus the validity of using normal lung tissues as a control 
was questionable.  Therefore, we generated gene lists by two different ways; one list 
shows the absolute gene expression levels from TB granulomas only, whereas the 
other list shows the differential gene expression levels of TB granulomas compared to 
normal lung tissue.  Interestingly, transcriptional profiles of TB granulomas derived 
both methods were comparable.  For the ease of data interpretation, we present the 
microarray data analyzed by differential gene expressions between TB granuloma and 
normal lung tissues.   
The microarray data analysis on caseous human pulmonary TB granulomas in 
this study revealed top biological functions; e.g. cell death, cell-mediated immune 
response, tissue morphology, and infection mechanism (Table 2.1).  Human PBMC-
derived macrophages from TB patients were shown to upregulate expressions of 
CCL3, CCL4, CXCL1, CXCL2, CXCL10, IL1B, and IL10 in response to Mtb infection 
[13], and BALF-cells from TB patients had upregulated genes such as IL7R, IL8, 
CXCR4, and CCL18 [14].  These reported genes for cytokines, chemokines, and their 
receptors were also highly upregulated in our microarray data (Table 2.2).  We 
previously showed that the cytokine production of macrophages in response to Mtb 
infection and mycobacterial trehalose dimycolate (TDM) requires CD14, MARCO, 
and TLR2 [15]; it is noteworthy that transcripts for these molecules are highly 
upregulated in human TB granulomas (Table 2.2).                
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Table 2.1 Top Biological Functions in Caseous Human Pulmonary TB Granulomas.  
The microarray data were analyzed by using Ingenuity Pathway Analysis®.   
 
Diseases and Disorders 
Name p-value No. of molecules 
Infectious Disease 9.48
−15–2.79−4 633 
Infection Mechanism 3.53
−14–2.79−4 498 
Immunological Disease  6.34
−11–3.39−4 995 
Cancer 1.05
−10–3.20−4 1406 
Reproductive System Disease 8.00
−10–2.80−5 352 
Molecular and Cellular Functions 
Name p-value No. of molecules 
Cell death 4.46
−26–3.00−4 1224 
Post-Translational Modification 2.08
−18–3.21−4 517 
Cellular Development 1.05
−16–3.28−4 821 
Cellular Function and Maintenance 1.70
−15–3.14−4 512 
RNA Post-Transcriptional Modification 1.05
−13–2.79−4 136 
Physiological System Development and Function 
Name p-value No. of molecules 
Organismal Survival 9.11
−13–4.57−5 488 
Hematological System Development and Function 1.05
−16–3.39−4 663 
Hematopoiesis 1.05
−16–1.12−4 388 
Tissue Morphology 4.68
−10–4.74−6 258 
Cell-Mediated Immune Response 1.70
−15–1.03−4 272 
Top Canonical Pathways 
Name p-value Ratio 
Protein Ubiquitination Pathway 1.27
−9
 98/201 (0.488) 
Molecular Mechanisms of Cancer 1.61
−9
 155/372 (0.417) 
Death Receptor Signaling 3.15
−9
 40/64 (0.625) 
Lymphotoxin β Receptor Signaling 1.62−8 37/61 (0.607) 
Induction of Apoptosis by Human Immunodeficiency Virus 1 2.63
−10
 42/65 (0.646) 
Top  Toxicity Lists 
Name p-value Ratio 
Pro-Apoptosis 2.16
−6
 28/42 (0.667) 
Mitochondrial Dysfunction 2.43
−5
 61/125 (0.488) 
Nuclear Factor-Kappa B signaling Pathway 2.19
−4
 53/112 (0.473) 
Retinoic Acid Receptor Activation 4.39
−4
 60/133 (0.451) 
Oxidative Stress Response Mediated by Nuclear Factor 2-Related Factor 2 5.99
−4
 86/205 (0.42) 
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Table 2.2 Caseous human pulmonary TB granulomas show upregulated gene 
expressions for immune response (P < 0.05). 
 
Cluster of Differentiation molecules 
Gene Description Fold change Gene Description Fold change 
CD3D CD3D molecule 48.6 CD59 CD59 molecule 107.3 
CD8A CD8A molecule 96.3 CD74 CD74 molecule 110.8 
CD14 CD14 molecule 399.6 CD80 CD80 molecule 13.1 
CD33 CD33 molecule 177.0 CD83 CD83 molecule 162.5 
CD44 CD44 molecule 106.3 CD86 CD86 molecule 48.7 
CD46 CD46 molecule 21.0 CD96 CD96 molecule 8.1 
CD53 CD53 molecule 162.2 CD163 CD163 molecule 890.1 
CD55 CD55 molecule 38.3 CD276 CD276 molecule 44.2 
Major Histocompatibility Complex molecules 
Gene Description Fold change Gene Description Fold change 
HLA-A MHC class I, A 52.2 HLA-DMA MHC class II, DM 
alpha 
55.2 
HLA-B MHC class I, B 328.6 HLA-DRA MHC class II, DR 
alpha 
95.7 
HLA-C MHC class I, C 645.2 HLA-DRB1 MHC class II, DR 
beta 1 
411.5 
HLA-DOA MHC class II, DO 
alpha 
28.4 HLA-E MHC class I, E 256.2 
HLA-DQB1 MHC class II, DQ, 
beta 1 
86.2 HLA-F MHC class I, F 848.7 
Receptors/Antigen recognition 
Gene Description Fold change Gene Description Fold change 
C3AR1 Complement component 
3a receptor 1 
56.1 MRC1 Mannose receptor, 
C type 1 
64.3 
C5AR1 Complement component 
5a receptor 1 
12.1 MRC2 Mannose receptor, 
C type 2 
93.4 
FCER1G Fc fragment of IgE, high 
affinity I, receptor for; 
gamma polypeptide 
141.7 MSR1 Macrophage 
scavenger  
receptor 1 
81.5 
FCGR2A 
(CD32) 
Fc fragment of IgG, low 
affinity, IIa, receptor 
126.8 SCARA5 Scavenger receptor 
class A, member 5 
25.5 
FCGR2B 
(CD32) 
Fc fragment of IgG, low 
affinity, IIb, receptor 
15.6 SCARB2 Scavenger receptor 
class B, member 2 
33.1 
FCGR3A 
(CD16a) 
Fc fragment of IgG, low 
affinity, IIIa, receptor 
12.2 SCARF1 Scavenger receptor 
class F, member 1 
22.5 
FCGR3B 
(CD16b) 
Fc fragment of IgG, low 
affinity, IIIb, receptor  
44.5 TLR1 Toll-like receptor 1 57.4 
MARCO Macrophage receptor 
with collagenous 
structure 
106.2 TLR2 Toll-like receptor 2 78.5 
TLR4 Toll-like receptor 4 20.1 
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Table 2.2 (Continued) 
 
Cytokines and cytokine receptors 
Gene Description Fold 
change 
Gene Description Fold 
change 
CSF1 Colony stimulating 
factor 1 
46.5 IL27RA Interleukin 27 receptor, alpha 14.0 
FAS Fas  44.8 IL32 Interleukin 32 39.4 
FASLG Fas ligand 9.1 LTA Lymphotoxin alpha 10.0 
IFNGR1 Interferon gamma 
receptor 1 
91.1 LTB Lymphotoxin beta 70.2 
IFNGR2 Interferon gamma 
receptor 2 
131.0 MIF Macrophage migration 
inhibitory factor 
14.5 
IL1B Interleukin 1, beta 26.9 MST1 Macrophage stimulating 1 16.3 
IL2RB Interleukin 2 
receptor, beta 
43.0 SCYE1 Small inducible cytokine 
subfamily E, member 1 
43.0 
IL4R Interleukin 4 
receptor 
12.7 TNFAIP1 TNF, alpha-induced protein 1 3.8 
IL6R Interleukin 6 
receptor 
9.2 TNFAIP2 TNF, alpha-induced protein 2 195.8 
IL7R Interleukin 7 
receptor 
27.8 TNFAIP3 TNF, alpha-induced protein 3 165.5 
IL8 Interleukin 8 43.6 TNFAIP8 TNF, alpha-induced protein 8 115.7 
IL10 Interleukin 10 28.1 TNFRSF1A TNF receptor superfamily, 
member 1A 
32.5 
IL12RB1 Interleukin 12 
receptor, beta 1 
36.0 TNFRSF1B TNF superfamily, member 1B 21.0 
IR13RA1 Interleukin 13 
receptor, alpha 1 
49.8 TNFRSF10B TNF receptor superfamily, 
member 10b 
148.8 
IL15 Interleukin 15 28.8 TNFRSF14 TNF receptor superfamily, 
member 14 
42.0 
IL15RA Interleukin 15 
receptor, alpha 
8.6 TNFRSF21 TNF receptor superfamily, 
member 21 
50.8 
IL17RA Interleukin 17, 
receptor A 
26.7 TNFSF4 TNF (ligand) superfamily, 
member 4 
12.8 
IL17RC Interleukin 17, 
receptor C 
15.7 TNFSF10 TNF (ligand) superfamily, 
member 10 
50.7 
IL21R Interleukin 21 
receptor 
17.0 TNFSF13B TNF (ligand) superfamily, 
member 13b 
497.7 
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Table 2.2 (Continued) 
 
Chemokines and chemokine receptors 
Gene Description Fold change Gene Description Fold change 
CCL1 Chemokine (C-C motif) 
ligand 1 
14.0 CCRL2 Chemokine (C-C 
motif) receptor-like 2 
17.7 
CCL2 Chemokine (C-C motif) 
ligand 2 
242.2 CKLF Chemokine-like 
factor 
146.8 
CCL3 Chemokine (C-C motif) 
ligand 3 
1028.9 CMKLR1 Chemokine-like 
receptor 1 
11.3 
CCL4 Chemokine (C-C motif) 
ligand 4 
19.3 CXCL1 Chemokine (C-X-C 
motif) ligand 1 
17.8 
CCL5 Chemokine (C-C motif) 
ligand 5 
17.3 CXCL2 Chemokine (C-X-C 
motif) ligand 2 
7.1 
CCL8 Chemokine (C-C motif) 
ligand 8 
41.4 CXCL9 Chemokine (C-X-C 
motif) ligand 9 
141.6 
CCL18 Chemokine (C-C motif) 
ligand 18 
85.7 CXCL10 Chemokine (C-X-C 
motif) ligand 10 
474.1 
CCR1 Chemokine (C-C motif) 
receptor 1 
277.4 CXCL12 Chemokine (C-X-C 
motif) ligand 12 
39.6 
CCR2 Chemokine (C-C motif) 
receptor 2 
5.9 CXCL16 Chemokine (C-X-C 
motif) ligand 16 
12.8 
CCR5 Chemokine (C-C motif) 
receptor 5 
138.4 CXCR4 Chemokine (C-X-C 
motif) receptor 4 
602.2 
CCR7 Chemokine (C-C motif) 
receptor 7 
39.2 CXCR7 Chemokine (C-X-C 
motif) receptor 7 
40.2 
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Table 2.2 (Continued) 
 
Signaling 
Gene Description Fold 
change 
Gene Description Fold 
change 
IFIT1 Interferon-induced protein 
with tetratricopeptide 
repeats 1 
15.1 MSN Moesin 61.0 
IFIT3 Interferon-induced protein 
with tetratricopeptide 
repeats 3 
67.1 MYD88 Myeloid differentiation 
primary response gene 
(88) 
18.6 
IL6ST Interleukin 6 signal 
transducer (gp130) 
22.4 PAG1 Phosphoprotein 
associated with 
glycosphingolipid 
microdomains 1 
1115.8 
INHBA Inhibin, beta A 54.5 SMAD3 SMAD family member 3 10.1 
INSIG1 Insulin induced gene 1 121.3 STAT6 Signal transducer and 
activator of transcription 
6, interleukin 4-induced 
10.0 
IRAK2 Interleukin-1 receptor-
associated kinase 2 
30.1 SYK Spleen tyrosine kinase 121.7 
IRAK3 Interleukin-1 receptor-
associated kinase 3 
66.0 TGFBR1 Transforming growth 
factor, beta receptor 1 
91.2 
MAP3K5 Mitogen-activated protein 
kinase kinase kinase 5 
340.8 TNIP3 TNFAIP3 interacting 
protein 3 
25.4 
MAPK1 Mitogen-activated protein 
kinase 1 
89.0 TRAF1 TNF receptor-associated 
factor 1 
8.1 
MAPK14 Mitogen-activated protein 
kinase 14 
125.5 TRAF3 TNF receptor-associated 
factor 3 
385.6 
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As well as immune response, other interesting themes have emerged from the 
microarray data: angiogenesis and tissue remodeling.  The formation of TB granuloma 
as an isolated independent structure in the lung parenchyma results from the 
recruitment of immunological cells from the blood stream and angiogenesis, followed 
by tissue remodeling [16-17].  While the tightly formed granuloma protects the host 
from Mtb dissemination to other parts of the body, the extensive tissue remodeling at 
the terminal stage of active TB leads to the granuloma liquefaction and erosion.  Our 
microarray study clearly demonstrates that tissue remodeling is very active in TB 
granuloma at the transcriptional level (Table 2.3).  Particularly, the increased secretion 
of MMP1 and MMP9 has been implicated in active TB disease in human [18-22]; 
these genes are highly upregulated (Table 2.3), and we observed MMP activity in 
human pulmonary TB granulomas by using in situ zymography (By Dr. Kaori 
Sakamoto, unpublished data).     
The most interesting theme from the microarray study is lipid metabolism.  An 
increasing body of literature has indicated that the host lipid metabolism changes upon 
mycobacterial infection.  Histological examination has demonstrated abundant lipids 
at the periphery of human TB granulomas and the presence of Mtb bacilli in lipid-rich 
areas including foamy macrophages and adipose tissues, and in vitro and in vivo 
mycobacterial infection studies indicate the accumulation of lipids in macrophages 
[23-28].  While the caseous center of human TB granuloma has been proposed to be 
filled with lipids, our microarray data present the first molecular evidence that lipid 
metabolism is highly active in caseous human TB granulomas.  Table 2.4 shows a 
subset of upregulated genes involved in lipid metabolism, and Ingenuity Pathway 
Analysis® generated pathway indicates most of upregulated genes are interconnected 
(Figure 2.2).  Moreover, many of them are unified around the pro-inflammatory  
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Table 2.3 Caseous human pulmonary TB granulomas show upregulated gene 
expressions for angiogenesis and tissue remodeling (P < 0.05). 
 
Proteolysis 
Gene Description Fold 
change 
Gene Description Fold 
change 
ADAMTS1 ADAM metallopeptidase 
with thrombospondin 
type 1 motif, 1 
4.3 MMP1 Matrix 
metallopeptidase 1 
606.2 
ADAMTS5 ADAM metallopeptidase 
with thrombospondin 
type 1 motif, 5 
16.0 MMP2 Matrix 
metallopeptidase 2 
16.2 
ADAMTS6 ADAM metallopeptidase 
with thrombospondin 
type 1 motif, 6 
9.9 MMP9 Matrix 
metallopeptidase 9 
199.9 
ADAMTS12 ADAM metallopeptidase 
with thrombospondin 
type 1 motif, 12 
7.3 MMP10 Matrix 
metallopeptidase 10 
14.9 
CASP2 Caspase 2 7.7 MMP19 Matrix 
metallopeptidase 19 
123.6 
CASP4 Caspase 4 24.4 
CASP6 Caspase 6 11.3 SERPINA1 Serpin peptidase 
inhibitor, clade A, 
member 1 
18.1 
CASP7 Caspase 7 5.9 
CASP8 Caspase 8 114.7 SERPINB1 Serpin peptidase 
inhibitor, clade B, 
member 1 
189.2 
CASP9 Caspase 9 16.0 
CASP10 Caspase 10 11.9 SERPINB9 Serpin peptidase 
inhibitor, clade B, 
member 9 
41.7 
CHI3L1 Chitinase-3-like 1 1042.5 
CTSA Cathepsin A 109.6 SERPINE1 Serpin peptidase 
inhibitor, clade E, 
member 1 
141.4 
CTSB Cathepsin B 127.6 
CTSC Cathepsin C 8.9 SERPINF1 Serpin peptidase 
inhibitor, clade F, 
member 1 
34.2 
CTSH Cathepsin H 9.3 
CTSK Cathepsin K 36.9 TIMP1 TIMP 
metallopeptidase 
inhibitor 1 
112.4 
CTSL1 Cathepsin L1 63.5 
CTSS Cathepsin S 340.3 TIMP2 TIMP 
metallopeptidase 
inhibitor 2 
44.3 
CTSZ Cathepsin Z 61.5 
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Table 2.3 (Continued) 
 
Fibrosis 
Gene Description Fold 
change 
Gene Description Fold 
change 
COL1A1 Collagen, type I, alpha 1 9.7 COL12A1 Collagen, type XII, 
alpha 1 
11.8 
COL3A1 Collagen, type III, alpha 
1 
254.4 COL14A1 Collagen, type XIV, 
alpha 1 
8.5 
COL4A1 Collagen, type IV, alpha 
1 
1.7 COL16A1 Collagen, type XVI, 
alpha 1 
2.2 
COL4A3BP Collagen, type I, alpha 1, 
alpha 3 binding protein 
81.9 COL18A1 Collagen, type XVIII, 
alpha 1 
4.6 
COL5A1 Collagen, type V, alpha 
1 
24.8 COL21A1 Collagen, type XXI, 
alpha 1 
6.2 
COL5A2 Collagen, type V, alpha 
2 
92.7 COL24A1 Collagen, type XXIV, 
alpha 1 
4.7 
COL5A3 Collagen, type V, alpha 
3 
23.9 COL25A1 Collagen, type XXV, 
alpha 1 
8.4 
COL6A2 Collagen, type VI, alpha 
2 
36.5 FBLN2 Fibulin 2 10.7 
COL6A3 Collagen, type VI, alpha 
3 
90.0 ITGA5 Integrin, alpha 5 29.2 
COL8A2 Collagen, type VIII, 
alpha 2 
25.9 ITGB1 Integrin, beta 1 103.8 
COL11A1 Collagen, type XI, alpha 
1 
142.0 LUM Lumican 14.8 
Angiogenesis 
Gene Description Fold 
change 
Gene Description Fold 
change 
CTGF Connective tissue growth 
factor 
235.3 PLAU Plasminogen activator, 
urokinase 
272.4 
HIF1A Hypoxia inducible factor 
1, alpha subunit 
61.0 PLAT Plasminogen activator, 
tissue 
161.0 
NRP1 Neuropilin 1 52.4 THBS2 Thrombospondin 2 95.7 
PDGFC Platelet derived growth 
factor C 
21.7 THBS3 Thrombospondin 3 18.5 
PDGFRA Platelet derived growth 
factor receptor, alpha 
polypeptide 
11.3 VCAN Versican 89.5 
PDGFRB Platelet derived growth 
factor receptor, beta 
polypeptide 
13.8 VEGFA Vascular endothelial 
growth factor A 
17.6 
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Table 2.4 Caseous human pulmonary TB granulomas show upregulated gene 
expressions for lipid metabolism (P < 0.05). 
 
Lipid synthesis and sequestration 
Gene Description Fold 
change 
Gene Description Fold 
change 
ABHD5 Abhydrolase domain 
containing 5 
34.3 GBA Glucosidase, beta, acid 32.0 
ACLY ATP citrate lyase 22.7 GLA Galactosidase, alpha 152.5 
ACSL1 Acyl CoA synthetase long 
chain family member 1 
39.4 GLB1 Galactosidase, beta 1 19.9 
ACSL3 Acyl CoA synthetase long 
chain family member 3 
71.2 GPD2 Glycerol-3-phosphate 
dehydrogenase 2 
60.9 
ACSL4 Acyl CoA synthetase long 
chain family member 4 
261.5 HADHA Hydroxyacyl-Coenzyme A 
dehydrogenase/3-ketoacyl-
Coenzyme A thiolase/enoyl-
Coenzyme A hydratase, 
alpha subunit 
11.0 
ACSL5 Acyl CoA synthetase long 
chain family member 5 
75.5 HMGCR 3-hydroxy-3methylglutaryl-
Coenzyme A reductase 
8.9 
ADFP Adipose differentiation-
related protein 
19.1 IDI1 Isopentenyl-diphosphate 
delta isomerase 1 
10.9 
CRAT Carnitine O-
acetyltransferase 
14.8 LIPA Lipase A, lysosomal acid, 
cholesterol esterase 
12.6 
CYP1B1 Cytochrome P450, family 
1, subfamily B, 
polypeptide 1 
36.5 LSS Lanosterol synthase 11.0 
CYP27A1 Cytochrome P450, family 
27, subfamily A, 
polypeptide 1 
48.0 PLSCR1 Phospholipid scramblase 1 11.8 
DEGS1 Degenerative 
spermatocyte homolog 1, 
lipid desaturase 
180.2 PSAP Prosaposin (precursor of 
sapC) 
14.6 
DHCR7 7-dehydrocholesterol 
reductase 
8.8 SCD Stearoyl-CoA desaturase 13.1 
EBP Emopamil binding protein 18.3 SC5DL Sterol-C5-desaturase 10.1 
ELOVL5 Elovl family member 5, 
elongation of long chain 
fatty acids 
36.8 SOAT1 Sterol O-acyltransferase 1 10.3 
FADS1 Fatty acid desaturase 1 45.0 SPHK2 Sphingosine kinase 2 11.6 
FDPS Farnesyl diphosphate 
synthase 
8.6 TPI1 Triosephosphate isomerase 1 12.4 
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Figure 2.2 The network of genes involved in lipid metabolism.  This was generated by 
using Ingenuity Pathway Analysis® program.  Genes in blue and yellow are 
upregulated in the array and shown in Table 2.4. 
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Figure 2.2 (Continued) 
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cytokine tumor necrosis factor- (TNF-, indicating that this response is consistent 
with a sustained pro-inflammatory stimulation. 
Despite the importance of understanding the granuloma biology in human TB 
pathogenesis, little has been known.  The current study has generated a genome-wide 
transcriptional profile of caseous human pulmonary TB granulomas and opened new 
avenues to investigate TB pathogenesis.  Future work includes further investigation of 
genes selected from the microarray data:  especially in lipid metabolism, cellular 
transmigration, and ER stress.   
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CHAPTER THREE 
LOCALIZATION OF ADFP, ACSL1, AND SAPC ON HUMAN PULMONARY 
TUBERCULOUS GRANULOMAS 
 
ABSTRACT 
Mycobacterium tuberculosis (Mtb) infection leads to the formation of granuloma at 
the infection site, and the well-stratified tuberculous (TB) granuloma prevents the 
escape of Mtb bacilli to other parts of the body but also provides a niche for Mtb, 
thereby protecting them from the host immune system.  Immunocompetent individuals 
may resolve TB granulomas by calcification or maintain the granuloma structure 
under control by constant immune system.  However, with unknown mechanism, TB 
granulomas start to extensively caseate or necrotize, and ultimately liquefy and 
cavitate into the open airway, transmitting the deadly Mtb bacilli to other individuals.  
Based on our microarray analysis showing upregulation of lipid metabolism, we 
examined localization of proteins involved in three different lipid metabolism 
processes on human pulmonary TB granulomas by immunohistology: adipose 
differentiation-related protein (ADFP), acyl-CoA synthetase long-chain family 
member 1 (ACSL1), and saposin C (SapC).  Our data show that caseous and 
fibrocaseous TB granulomas have strong expressions of ADFP, ACSL1, and SapC, 
whereas old, resolved TB granulomas do not.  SapC expression is detected in early TB 
granulomas.  In summary, our data indicate that Mtb infection causes dysregulated 
lipid metabolism in the human host, and this transition correlates with the 
accumulation of lipids as caseum in human TB granuloma.  
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INTRODUCTION 
Shortly after infection, the tissue site becomes organized into a granuloma, 
which comprises of the core of infected macrophages surrounded by foamy and 
epithelioid macrophages, monocytes, and multinucleated giant cells (MGCs).  The 
periphery of the granuloma is marked by fibroblasts that lay down a fibrous capsule 
around the macrophage-rich granuloma.  Once the capsule is formed, lymphocytes are 
scarce within the granuloma center and are most abundant outside this fibrous capsule.  
In this state, the granuloma represents a stable structure that maintains a constant 
bacterial load but does not cause any overt signs of disease in the infected individual.  
Immunocompetent or antibiotic-treated individuals can resolve tuberculous (TB) 
granulomas, disaggregating recruited leukocytes, dissolving extracellular matrix, 
thereby restoring the normal pulmonary structure.  However, 5~10 % of infected 
individuals develop active TB disease after the initial infection.  Pulmonary TB 
disease is seen about 85% of individuals with active disease [1], although this 
proportion dramatically changes in human immunodeficiency virus (HIV)-infected 
individuals who develop pulmonary TB (38%), extrapulmonary TB (30%), and both 
pulmonary and extrapulmonary (32%) [2-3].  As TB transmission occurs via Mtb-
containing aerosols released from the cavitated, ruptured pulmonary granuloma, it is 
critical to understand the mechanism of TB granuloma development.      
 Accumulation of lipids has been linked to metabolic syndromes and diseases 
including diabetes, sepsis, Chagas’ disease, hepatitis C virus infection, and acquired 
immune deficiency syndrome (AIDS) [4-8].  Foamy or lipid-droplet filled 
macrophages are the fundamental component of atherosclerosis and are becoming 
recognized as a consequence of chronic inflammatory stimuli [9].  Previous reports 
documented the abundance of foam cells in human TB lung tissues [10-11].  In 
addition, virulent Mtb or M. bovis Bacillus Calmette-Guérin (BCG) infection triggers 
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accumulation of lipid droplets in macrophages in vitro [11-12], suggesting Mtb 
stimulates the accumulation of host lipids.  The progression of latent TB toward active 
disease correlates with the increased accumulation of caseum, which is thought to 
result from the death of macrophages and other leukocytes in the granuloma center.  
The granuloma becomes increasingly necrotic until the center liquefies, and it 
cavitates and ruptures into the lung airway [13-14].  Our microarray data have 
indicated that tissue remodeling is active in caseous human pulmonary TB granulomas 
(Table 2.2) and genes for lipid metabolism are also highly upregulated (Table 2.3 and 
Figure 2.2). 
 To test our hypothesis that the extensive lipid accumulation as caseum 
contributes to the expansion of the granuloma with the ultimate tissue breakdown, we 
decided to examine whether proteins responsible for lipid synthesis and sequestration 
could be detected on human pulmonary TB granulomas.  By immunohistological 
analysis, it was very clear that three proteins, ADFP, ACSL1, and SapC, were highly 
expressed in cells of caseous and fibrocaseous granulomas, but resolved granulomas 
did not show any appreciable expression.  These data argue that the host undergoes 
metabolic shift during Mtb infection and that lipids accumulate inside progressive TB 
granulomas.  
 
 
MATERIALS and METHODS 
Human Subjects  
Human subjects were included in this study according to protocols approved by 
Institutional Review Boards at University of Cape Town, South Africa, the Public 
Health Research Institute, Newark, NJ, and Cornell University, Ithaca, NY.  Informed 
consent was obtained from all of the patients.   
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Histology  
Human TB lung tissues embedded in paraffin were cut at 3 µm thickness and stained 
with hematoxylin and eosin for histological examination, after which images were 
taken by Leica CM300 camera (v1.0, Leica Microsystems) attached to Axiophot (Carl 
Zeiss MicroImaging) with Leica IM50 software (v1.20, Leica Microsystems).  All the 
slides were reviewed by a pathologist, M. Locketz (Department of Pathology, 
University of Cape Town, South Africa).   
For the detection of neutral lipids, cryosections of human TB lung tissues were fixed 
in 4% paraformaldehyde in PBS for 30 min and either stained with 0.3% Oil Red O 
(Alfa Aesar) and counterstained with hematoxylin or stained with 10µg/ml BODIPY 
493/503 (Invitrogen) and 1µg/ml DAPI (Invitrogen).  Images were photographed by 
AxioCam HRc attached to Zeiss Axio Imager with AxioVision LE software (Carl 
Zeiss MicroImaging).   
 
Immunohistology 
For immunohistological study of human pulmonary TB tissues, paraffin-embedded 
sections were cut at 3 µm thickness, heat-fixed, deparaffinized and rehydrated.  
Epitopes were heat-retrieved in a pressure cooker with 1 mM EDTA buffer pH 8.0, 
and tissue sections were blocked with 0.2% gelatin in PBS with 0.05% Tween-20 
(PBS-T) at room temperature for 1 h.  Mouse monoclonal antibody against human 
ADFP (1:100, RDI division of Fitzgerald Industrial Intl.), rabbit polyclonal antibody 
against human ACSL1 (1:150, GenWay Biotech), or rabbit polyclonal antibody 
against human SapC (1:50, Santa Cruz Biotechnology) were applied to the samples at 
37°C for 1 h.  After washing with PBS-T three times, samples were incubated with 1% 
Sudan Black B (Sigma) in 70% ethanol at room temperature for 10 min.  Sections 
were washed with PBS-T three times and incubated with Cy3™-goat antibody against 
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mouse (H+L) (1:250, Jackson ImmunoResearch) or Cy3™-goat antibody against 
rabbit (H+L) (1:250, Jackson ImmunoResearch) at room temperature for 45 min.  
After PBS-T wash, nuclei were stained with 1μg/ml of DAPI at room temperature for 
10 min, followed by thorough wash with PBS-T.  Slides without primary antibodies 
and normal lung tissues were included as controls.  Tissue sections were mounted in 
ProLong Gold Antifade Reagent and images were captured by AxioCam MRm 
attached to Zeiss Axioskop 40 epifluorescence microscope with AxioVision 4.3 
software (Carl Zeiss MicroImaging).  Further image analysis was done by AxioVision 
LE software (Carl Zeiss MicroImaging) and Adobe Photoshop CS2 (Adobe). 
 
RESULTS and DISCUSSION 
            Despite the critical importance of understanding TB granuloma biology, few 
studies have looked beyond immune mechanisms to probe the underlying pathology 
required to generate active disease.  As recent studies and our microarray study on 
human TB granulomas (Chapter 2) point to the involvement of lipid metabolism in TB 
pathogenesis [10-12], we decided to investigate whether proteins involved in lipid 
metabolism could be detected in human TB granulomas by immunohistology.   
            From the upregulated genes in human TB granulomas (Table 2.3 and Figure 
2.2), we focused on three proteins relevant to three different aspects of lipid 
sequestration and metabolism: ADFP, ACSL1, and SapC.  Excess lipids are stored in 
an organelle, the lipid droplet, which is formed through either the sequestration of 
cholesteryl esters (CE) from LDL-derived cholesterol or from lipids synthesized de 
novo by cells.  ADFP is known to be required for lipid droplet formation and it 
remains strongly associated with the periphery of lipid droplets [15].  Upregulated 
ADFP expression increases sequestration of CE, increases synthesis of long-chain 
fatty acid (LCFA) and triacylglycerols (TAG), and inhibits catalysis of lipids through 
 71 
 
the β-oxidation pathway [15-18].  ADFP mRNA is increased by excess LCFA, fasting, 
modified low density lipoprotein (LDL), Peroxisome proliferator-activated receptor 
(PPAR) agonists, or transcription factors that play a role in lipid homeostasis [19-23].  
ACSL1, the acyl-CoA synthetase, can also lead to lipid droplet formation through the 
de novo synthesis of long chain fatty acids that are incorporated into TAG [24-25].  
ACSL1 mediates the formation of fatty acyl-CoA esters from fatty acids of carbon 
length 14 to 24, a key step for lipid biosynthesis, and it is proposed to be present on 
the plasma membrane, mitochondria, and lipid droplets.  Finally, the prosaposin 
product, saposin C (SapC, sphingolipid activator protein), is required for the turnover 
of glycosphingolipids into ceramide and sphingosine in the inner endosomal and 
lysosomal membranes, an essential activity to maintain the balance of lipid species in 
biological membranes [26-27].  In addition to glycolipid degradation, SapC is known 
to function as a transfer protein by loading Mtb glycolipid, lipoarabinomannan 
(LAM), onto the antigen-presenting molecule, CD1b [28-29].  For our study, we 
focused on the role of SapC in glycosphingolipid metabolism.  
            Using immunohistological analysis, we investigated the localization and 
relative expression levels of ADFP, ACSL1, and SapC on human pulmonary TB 
granulomas representing different stages of disease progression.  Granulomas from 32 
cases were categorized into four stages:  nascent (n=28), caseous (n=16), fibrocaseous 
(n=66), and resolved granulomas (n=9) (Figure 3.1).   
            The expression profile of the lipid droplet-associated protein, ADFP, varied 
markedly at each stage of granuloma development.  Nascent granulomas showed weak 
or minimal staining, whereas caseous and fibrocaseous granulomas showed the 
abundant expression of ADFP (Figure 3.2 A–F).  Macrophages and MGCs around the 
fibrotic capsule showed the most intense staining pattern.  It is noteworthy that the 
actual caseum of several granulomas revealed strong expression of ADFP mingled  
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Figure 3.1 Human pulmonary TB granulomas are categorized into four stages 
Nascent (A: ×10) Caseous (B: ×10) Fibrocaseous (C: ×4) Resolved (D: ×4) 
 
A 
B 
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Figure 3.1 (Continued)  
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Figure 3.2 ADFP expression pattern at different stages of human pulmonary TB 
granulomas. 
Representative images are shown here. The same exposure time was used for all of the 
images. 
A: ADFP (red) expression in early granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in B. ×20    
B: H&E-stained early granuloma. ×10 
C: ADFP (red) expression in caseous granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in D. ×200    
D: H&E-stained caseous granuloma. ×1.25 
E: ADFP (red) expression in fibrocaseous granulomas (nuclei in blue) is shown here.  
Its corresponding area is shown in a box in F. ×20    
F: H&E-stained fibrocaseous granuloma. ×1.25 
G: ADFP (red) expression at the caseous center (nuclei in blue).  Its corresponding 
area is shown in a box in H. ×20    
H: H&E-stained caseous granuloma. ×4 
I: ADFP (red) expression in resolved granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in I. ×20    
J: H&E-stained caseous granuloma. ×4 
K: ADFP (red) expression in normal lung parenchyma (nuclei in blue). ×20 
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Figure 3.2 (Continued) 
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Figure 3.2 (Continued) 
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Figure 3.2 (Continued) 
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Figure 3.2 (Continued) 
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Figure 3.2 (Continued) 
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with nuclear debris, indicating that the lipids of the caseum were likely derived from 
lipid droplets sequestered within foam cells upon apoptotic or necrotic cell death 
(Figure 3.2 G&H).  Finally, resolved or calcified granulomas lacked detectable ADFP 
label (Figure 3.2 I&J).  Type II pneumocytes produce surfactant proteins to reduce 
surface tension, and the surfactant proteins are recycled by type II pneumocytes and 
alveolar macrophages.  As a result, those cells possess lipid droplets, and ADFP was 
detected in healthy lung parenchyma (Figure 3.2 K).       
The expression pattern of ACSL1 was very similar to that of ADFP.  Nascent 
granulomas had almost no staining, while MGCs occasionally showed very weak 
staining (Figure 3.3 A&B).  In contrast, the cellular regions subtending the capsules of 
caseous and fibrocaseous granulomas were robustly stained with ACSL1 antibody 
(Figure 3.3 C-F).  Similar to ADFP, resolved granulomas showed no ACSL1 
expression, with the exception of a few cells (Figure 3.3 G&H).  Since ACSL1 is 
important for normal cellular functions, it was detectable in the normal lung 
parenchyma (Figure 3.3 I).    
             SapC expression was different from both ADFP and ACSL1 in that it was 
strongly expressed in macrophages and MGCs even in nascent granulomas (Figure 3.4 
A&B).  In caseous and fibrocaseous granulomas, SapC was expressed along the 
capsule that contained many macrophages and MGCs (Figure 3.4 C–F).  Similarly to 
ADFP and ACSL1, SapC expression was not detected in resolved granulomas (Figure 
3.4 G&H).  By immunohistology, there was no detectable level of SapC expression in 
normal lung tissues (data not shown).  
In addition to the detection of proteins involved in lipid synthesis and 
accumulation, lipid-laden foam cells were frequently seen in caseous granulomas and 
in the alveoli and respiratory bronchioles (Figure 3.5 A&B).  Lipids were readily 
detected by neutral lipid staining (Figure 3.5 C&D).   
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Figure 3.3 ACSL1 expression pattern at different stages of human pulmonary TB 
granulomas.  Representative images are shown here.  The same exposure time was 
used for all of the images. 
A: ACSL1 (red) expression in early granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in B. ×20    
B: H&E-stained early granuloma. ×10 
C: ACSL1 (red) expression in caseous granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in D. ×20    
D: H&E-stained caseous granuloma. ×4 
E: ACSL1 (red) expression in fibrocaseous granulomas (nuclei in blue) is shown here.  
Its corresponding area is shown in a box in F. ×20    
F: H&E-stained fibrocaseous granuloma. ×4 
G: ACSL1 (red) expression in resolved granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in I. ×20    
H: H&E-stained caseous granuloma. ×4 
I: ACSL1 (red) expression in normal lung parenchyma (nuclei in blue). ×20 
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Figure 3.3 (Continued) 
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Figure 3.3 (Continued)  
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Figure 3.3 (Continued) 
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Figure 3.3 (Continued) 
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Figure 3.4 SapC expression pattern at different stages of human pulmonary TB 
granulomas. 
Representative images are shown here. 
A: SapC (red) expression in early granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in B. ×20    
B: H&E-stained early granuloma. ×10 
C: SapC (red) expression in caseous granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in D. ×20    
D: H&E-stained caseous granuloma. ×4 
E: SapC (red) expression in fibrocaseous granulomas (nuclei in blue) is shown here.  
Its corresponding area is shown in a box in F. ×20    
F: H&E-stained fibrocaseous granuloma. ×1.25 
G: SapC (red) expression in resolved granulomas (nuclei in blue) is shown here.  Its 
corresponding area is shown in a box in I. ×20    
H: H&E-stained caseous granuloma. ×4 
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Figure 3.4 (Continued) 
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Figure 3.4 (Continued) 
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Figure 3.4 (Continued) 
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Figure 3.5 Lipid-laden foam cells in caseous granulomas and alveolar spaces.  Alveoli 
and respiratory bronchioles are full of foamy macrophages (A: ×20, H&E on paraffin 
section, C: Oil red O staining for neutral lipids on cryosection).  Foam cells are present 
at the periphery of caseous granulomas (B: ×20, H&E on paraffin section, D: Oil red 
O staining for neutral lipids on cryosection). 
Arrows indicate foam cells. 
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Figure 3.5 (Continued) 
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           The immunohistological analysis of human TB granulomas has generated a 
picture that enables us to form a more dynamic interpretation of granuloma 
progression.  Both ADFP and ACSL1 play a role in lipid accumulation through either 
sequestration or de novo synthesis, and the increased expression of ADFP and ACSL1 
in caseous and fibrocaseous granulomas indicates that the advanced form of TB 
granulomas accumulate lipids.  In contrast to ADFP and ACSL1, SapC was expressed 
very strongly in nascent granulomas, and this may indicate that cells undergo a 
metabolic shift early on before starting to accumulate the massive amount of lipids in 
the form of caseum.  SapC in TB granulomas may play a role in transferring Mtb lipid 
antigens for T cell activation.   
The data presented here provide compelling evidence that the development of 
the lipid-rich caseum in the human TB granuloma results from a re-alignment in lipid 
metabolism within the granuloma.  Ongoing and future studies include the 
investigation of specific host and Mtb factors that drive the accumulation of lipids 
inside TB granulomas.  Investigations to understand the temporal and spatial 
regulation of lipid metabolism in human TB granulomas of different stages are 
warranted.          
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CHAPTER FOUR 
LIPID ANALYSIS OF CASEUM FROM HUMAN PULMONARY 
TUBERCULOUS GRANULOMAS 
 
ABSTRACT 
In response to Mycobacterium tuberculosis (Mtb) infection, host cells secrete various 
cytokines and chemokines, recruiting leukocytes to the site of infection.  This process 
results in the formation of tuberculous (TB) granuloma at the infection focus.  
Immunocompetent individuals infected with Mtb control the infection by confining 
the bacilli inside TB granuloma or by eliminating the bacilli completely.  However, 
people with immunosuppressive conditions develop an active disease, at which TB 
granulomas extensively caseate, liquefy and cavitate.  Since TB transmission occurs 
via Mtb-containing aerosol droplets released from the cavitated granulomas, it is 
important to understand how TB granuloma caseates and cavitates.  It has been 
hypothesized that the caseum is filled with lipids.  Therefore, we performed lipid 
analysis of caseum of human pulmonary TB granulomas and demonstrated that the 
caseum contained more neutral lipids, cholesterol (CHO), cholesteryl esters (CE), and 
triacylglycerols (TAG), and glycosphingolipid, lactosylceramide, than normal lung 
parenchyma.  We propose that, during active TB state, the host undergoes a dramatic 
shift in lipid metabolism, accompanied by the accumulation of lipids in form of 
caseum, and that the expansion of lipid contents in the caseum may result in the 
liquefaction and cavitation.  Furthermore, these lipids may also serve as a carbon 
source for Mtb bacilli.      
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INTRODUCTION 
Mycobacterium tuberculosis (Mtb)-containing aerosol droplets are inhaled by 
the host, followed by phagocytosis by alveolar macrophages.  The infected cells 
secrete various cytokines and chemokines and recruit leukocytes to the site of the 
infection.  The leukocytes form a solid structure, tuberculous (TB) granuloma.  TB 
granuloma is two-sided in that it protects the host by confining Mtb bacilli into the 
localized nodule, and on the other hand, it protects Mtb bacilli from host immunity 
within the stratified nodule.  When the host fails to keep the infection under control or 
the bacteria succeed in multiplying and destroying the host cells, TB is reactivated.  At 
this stage, the caseous TB granuloma liquefies and cavitates, and the TB granuloma 
ruptures into the airway space, and Mtb bacilli grow on the open surface of cavitary 
granuloma [1-3].  It is still unclear what drives the latency into active TB, although 
immunosuppressive conditions including aging, acquired immune deficiency 
syndrome (AIDS), cancer, and malnutrition are known to raise the risk of developing 
active TB.     
Based on the cheesy appearance, the center of the granuloma is called caseum 
or caseous center.  The caseum of human pulmonary TB granulomas has been thought 
to be filled with lipids, although there is no direct biochemical evidence.  Pagel’s 
group reported abundant lipids in Mtb-infected human tissues histologically [4], 
followed by Caldwell who analyzed the lipid composition of caseous materials that 
included human and bovine lymph nodes and livers.  Their studies demonstrated that a 
higher percentage of cholesterol (CHO) was found in caseous materials as compared 
to control tissue samples [5].  Further, Kondo et al. [6-7] demonstrated that virulent 
Mtb infection induced the accumulation of cholesteryl esters (CE) in murine lung in 
vivo and murine peritoneal macrophages in vitro.  Recent findings that virulent Mtb or 
Mycobacterium bovis Bacillus Calmette Guérin (BCG) infection triggers the formation 
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of lipid droplets in macrophages in vitro indicate the active involvement of the bacilli 
in modulating the host lipid metabolism [8-9].   
We have shown that genes involved in lipid metabolism were highly 
upregulated in caseous human pulmonary TB granulomas and also that adipose 
differentiation-related protein (ADFP), acyl CoA-synthetase long chain family 
member 1 (ACSL1), and saposin C (SapC), responsible for lipid metabolism and 
storage, were expressed very strongly in caseous granulomas (Chapter 2&3).  These 
data argue that recruited cells to the site of infection undergo a dramatic change in 
lipid metabolism in response to Mtb infection and that lipids accumulate progressively 
inside human TB granulomas in the form of caseum.  To test our hypothesis, we 
analyzed the lipid composition of caseum from human pulmonary TB granulomas.  By 
using thin layer chromatography (TLC) and mass spectrometry (MS) analyses, our 
data showed that caseum had more CHO, CE, and triacylglycerols (TAG) than normal 
lung parenchyma.  Moreover, we found a unique lipid species that was significantly 
abundant in caseum but low in normal tissues.  This lipid was identified as 
lactosylceramide (LacCer).  In addition, Mtb bacilli were detected histologically 
throughout the granuloma including caseum.  These data support our hypothesis that, 
in the localized nodule, leukocytes experience a metabolic shift in response to Mtb 
infection, culminating in the extensive accumulation of neutral lipids and glycolipids, 
in the form of caseum.                   
 
MATERIALS AND METHODS 
Lipid analysis 
Frozen human TB lung tissues or normal lung tissues were thawed, and caseum or 
normal tissue segments were isolated and transferred into glass vials (Wheaton 
Science) and then mixed with chloroform:methanol (2:1, v/v).  The corresponding 
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materials were microscopically confirmed by histological staining.  After sonication at 
50°C for 1 h, the extracts were filtered through a 0.2 µm-pore size PTFE membrane 
(GD/X® syringe filter, Whatman) and dried down using nitrogen.  TLC plates 
(aluminum-backed Silica gel 60 plates, EMD) were pre-run in chloroform:methanol 
(90:10, v/v) to remove any contaminants from silica gel followed by heat-activation at 
110°C for 30 min.  Total lipids were developed either in a dual solvent system of 
chloroform:methanol:water (65:25:4, v/v/v) and petroleum ether:ethyl ether:acetic 
acid (70:30:2, v/v/v) or in a single solvent system of chloroform:methanol:water 
(65:25:4, v/v/v).  Plates were sprayed with 50% sulfuric acid in ethanol and charred 
for detecting lipid species.  The lipid standards used were cholesteryl oleate, TAG, 
cardiolipin, and phosphatidylcholine (Sigma), CHO (MP Biomedicals), sphingomyelin 
(SM) (Avanti Polar Lipids), and neutral glycosphingolipid qualmix (Matreya).   
 
Electrospray (ESI) tandem quadrupole mass spectrometric analysis of lipids 
Structural analysis of lipids including SM, LacCer, CE, and TAG were carried out by 
a Finnigan TSQ-7000 triple stage quadrupole mass spectrometer (Thermo Electron 
Corporation, CA) equipped with a Finnigan ESI source and controlled by Finnigan 
ICIS software operated on a DEC alpha workstation.  Lipid extract dissolved in 
methanol/chloroform (2:1, v/v) were continuously infused into the ESI source with a 
Harvard syringe pump at a flow rate of 1µL/min.  The skimmer was at ground 
potential, and the electrospray needle was at 4.5 kV.  The heated capillary temperature 
was 250°C.  The collisionally activated dissociation (CAD) tandem mass spectra were 
obtained under collision energy from 30 to 45 eV, and argon (2.3 mTorr) was used as 
target gas.  The product ion spectra were acquired in the profile mode at the scan rate 
of one scan per 3 sec.  Structural characterization of CH was conducted by Agilent 
5973 MSD GC/MS system operated by ChemStation software.  Lipid extract in 
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methanol/chloroform (2:1, v/v) was injected into a Hewett-Packard 6890 GC in a 
splitless mode and analyzed with a 15 m DB-1701 column (0.25 mm i.d, 0.25 µm film 
thickness; J & W Scientific).  The initial temperature of GC was set at 100°C for 1 
min, increased to 220°C at a rate of 50°C/min, then to 290°C at a rate of 10°C/min and 
maintained at 290°C for another 10 min.  The temperatures of the injector, transfer 
line of the GC column and of the ion-source were set at 280°C, 280°C and 230°C, 
respectively.  The full scan mass spectra (50–500 Da) were acquired at a rate of 1 
scan/0.25 Sec.  Mass spectrometry was performed by Dr. Fong-Fu Hsu (Washington 
University School of Medicine). 
 
Mycobacterium staining on human lung tissues 
Paraffin-embedded sections of human TB lung tissues were heat-fixed, deparaffinized, 
and rehydrated.  The sections were incubated with auramine-rhodamine (EM Science) 
for 30 min at 60°C, washed with dd-H2O, differentiated in 1% HCl in 70% ethanol for 
30 sec, and washed.  The section was blocked with 1% Sudan Black in 70% ethanol, 
washed with dd-H2O, counterstained with Harris hematoxylin, and then mounted with 
Fluoromount G (Southern Biotech).  Images were captured by AxioCam HRc attached 
to Zeiss Axio Imager with AxioVision LE software (Carl Zeiss MicroImaging).   
 
RESULTS and DISCUSSION 
Since TB transmission occurs via Mtb-containing aerosols released from 
cavitated pulmonary TB granulomas, it is critical to understand the biology of TB 
granulomas.  TB granuloma is a collection of leukocytes formed upon Mtb infection. 
It can be resolved or remain dormant.  However, it is with still unclear how TB 
granuloma caseates and cavitates.  To understand this process, we examined gene and 
protein expression of human pulmonary TB granulomas (Chapter 2&3) and showed 
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that lipid metabolism plays an important role in cells of caseous granulomas.  In order 
to determine if upregulated expression of genes and proteins for lipid metabolism lead 
to any change in lipid profiles, we analyzed lipids of actual caseum from human 
pulmonary TB granulomas.   
 Total lipids were extracted from the caseum of caseous and fibrocaseous 
granulomas and they were compared to lipids obtained from normal lung tissues.  TLC 
analysis revealed significant differences in lipid profiles; caseum materials showed 
increased amounts of neutral lipids, CHO, CE, and TAG (Figure 4.1).  In addition, a 
unique lipid double band was detected in the caseum which was not detectable in 
normal lung tissues (Figure 4.2).  It showed the same color and migration pattern to 
standard lactosylceramide (LacCer).   
We also performed mass spectrometry (MS) to confirm lipid identities.  The 
MS profile of SM was obtained by precursor-ion scan of m/z 184.  The spectrum 
contained the whole array of the protonated SM species consisting of 18:1-sphingosine 
long chain base with 16:0 (m/z 703), 22:0 (m/z 787), 24:2 (m/z 811), 24:1 (m/z 813), 
and 24:0 (m/z 815) fatty acyl groups, respectively (Figure 4.3 A).  This profile was 
similar to that obtained by neutral loss scan of m/z 183 (Figure 4.3 B), which 
contained the ion series at m/z 725, m/z 809, m/z 833, m/z 835, and m/z 837 that were 
22 Da heavier than the corresponding [M + H]
+
 ions, further supporting the presence 
of sphingomyelins.  The MS profile of LacCer was obtained by neutral loss scan of 
m/z 162, an unique loss of a sugar moiety that specifically detects the [M + Na]
+
 ions 
of LacCer (Figure 4.3 C).  The spectrum was dominated by the ion at m/z 884, 
corresponding to a d18/16:0-LacCer, along with ions at m/z 968, m/z 994, and m/z 996, 
representing the [M + Na]
+
 ions of d18:1/22:0, d18:1/24:1, and d18:1/24:0 LacCer, 
respectively.  The tandem mass spectrum was obtained by precursor-ion scan of m/z 
369, a signature fragment ion that is commonly seen for CE, following collision  
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Figure 4.1 Lipid analysis of caseum and normal lung tissue by thin-layer 
chromatography. 
Total lipids were extracted from normal lung tissues (lane 4-6, 120 µg) and caseum 
(lane 7-9, 120 µg), and then run in parallel with total lipids from Mtb CDC1551 (lane 
1, 400 µg), and standard lipids, cardiolipin (lane 2, 50 µg), phosphatidylcholine (lane 
3, 50 µg), cholesterol (CHO, lane 10, 20 µg), cholesteryl ester (CE, lane 11, 25 µg), 
and triacylglycerol (TAG, lane 12, 20 µg).  The caseum reveals higher amounts of 
CHO, CE, and TAG (dual solvent system).  Caseum samples were derived from 
granulomas of seven TB patients, and normal lung tissue samples were from 
unaffected lung areas of another seven TB patients.  Three representative lipids of 
caseum and normal lung tissue are shown in this analysis.    
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Figure 4.2 Lipid analysis of caseum by thin-layer chromatography. 
Total lipids from the caseum (lane 2, 120 µg) were separated by TLC.  As standards, 
sphingomyelin (SM, lane 1, 5 µg) and neutral glycosphingolipids (lane 3, 30 µg) were 
used.  Caseum samples derived from granulomas of seven TB patients showed the 
same pattern, and one representative sample is shown in this analysis.  LacCer is 
indicated. 
 
 
 
 
    1              2             3 
LacCer 
 109 
 
 
 
 
 
Figure 4.3 Mass spectrometric analyses of sphingomyelin (A&B), lactosylceramide 
(C), cholesteryl esters (D), triacylglycerols (E), and cholesterol (F&G) derived from 
caseum of human pulmonary TB granulomas.  Data from one representative sample 
are shown. 
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Figure 4.3 (Continued)  
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activation dissociation on the [M + Na]
+
 ions.  The spectrum contained the major ions 
at m/z 671 and m/z 673, corresponding to the sodiated species of cholesteryl linoleate 
and cholesteryl oleate, respectively (Figure 4.3 D).  The MS profile revealed the major 
[M + NH4]
+
 ions of TAG that consisted of 16:0-, 16:1-, 18:0-, 18:1-, and 18:2-fatty 
acid substituents on the glycerol backbone (Figure 4.3 E).  The spectrum was 
dominated by the ions at m/z 876 corresponding to the ammoniated TAG species 
possessing a total of C52 with the presence of 2 total unsaturated bonds situated on the 
fatty acyl chains (52:2), and at m/z 902 (54:3), m/z 820 (48:2), m/z 822 (48:1), m/z 834 
(49:2), m/z 836 (49:1), m/z 848 (50:2), m/z 850 (50:1), m/z 874 (52:3), m/z 900 (54:4), 
and m/z 904 (54:2).  The electron impact (EI) gas chromatography/mass spectrometry 
(GC/MS) and total ion current (TIC) chromatogram gave a peak at 12.23 min (Figure 
4.3 F) and an EI mass spectrum (Figure 4.3 G) identical to that arising from CHO 
standard, and the retention time is also identical to that of authentic standard, 
confirming the presence of cholesterol.  
CHO has long been linked to TB, although its role in TB pathogenesis is 
contradictory.  The administration of CHO-rich diets to TB patients reduced the 
number of bacilli in the sputum [10-13].  In contrast to the beneficial effects of  
cholesterol on TB patients, when hypercholesterolemia was induced in mice through 
deletion of ApoE prior to Mtb infection, the high cholesterol accelerated bacterial 
growth and exacerbated the lung pathology [14].  Recent studies demonstrated the 
ability of Mtb to utilize host-derived CHO in vitro and in vivo [15-18].  It is also 
known that CHO-enriched microdomains of phagocytes facilitate mycobacterial 
uptake and ensure bacterial intracellular survival [19-20].  As TB patients are 
weakened by the disease, administration of CHO-rich diet is likely to benefit patients.  
On the other hand, the confined environment of TB granuloma with CHO-rich caseum 
may promote the survival of Mtb bacillus by its capability to degrade CHO as a carbon 
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source [15, 17-18].  However, further investigations are needed to characterize the 
role(s) of CHO in TB pathogenesis.   
Mycobacteria are also known to accumulate TAG under stress, e.g. starvation 
and hypoxia, and utilize it during the chronic infection period.  Mtb bacilli containing 
TAG-rich intracellular lipophilic inclusions (ILIs) were detected in sputum samples 
from TB patients [21-24].  However, further studies need to be done to determine 
whether dysregulated lipid metabolism of the host contributes to TAG accumulation in 
the caseum. 
 In addition to CHO and TAG, Mtb infection was shown to induce the 
accumulation of CE in vitro and in vivo [6-7].  Interestingly, the presence of CE in 
caseous intracranial TB granulomas has been proposed to be a disease marker [25].  It 
is not clear if CE serves as a carbon source for Mtb or is a product of pathological 
changes in the host.  However, it is clear from our data and previous literature that 
Mtb infection leads to dysregulated lipid metabolism of the host and this culminates in 
the accumulation of CE in the form of caseum.   
LacCer is an extremely interesting glycosphingolipid to be found in TB 
granuloma caseum with respect to its biological properties.  LacCer is normally 
present in trace amounts in mammalian cells because it is an intermediate in the 
glycosphingolipids biosynthesis.  Its accumulation in cells could result from either 
increased ceramide synthase activity, increased catabolism of complex ceramides or 
proinflammatory factors [26].  LacCer in phagocytes is also implicated in innate 
immunity by forming membrane microdomains; LacCer may serve as a pattern 
recognition receptor for pathogens including mycobacteria, thereby leading to signal 
transduction and phagocytosis [27-30].  Particularly, LacCer that contains very long 
fatty acid C24:0 and C24:1 chains is known to be critical for LacCer-mediated 
functions [31], and LacCer identified in our analysis on caseum of human TB 
 115 
 
granuloma also contained long chain fatty acids (Figure 4.3 C, and page 6).  Even 
though we cannot rule out the role of LacCer in bacterial recognition, our biochemical 
data seem to point to the role(s) of LacCer in glycosphingolipid metabolism rather 
than phagocytic function.  The excess accumulation of LacCer in the caseum is tightly 
associated with the high expression of SapC in nascent and caseous granulomas; SapC 
mediates the degradation of LacCer into glucosylceramide (GlcCer) by β-
galactosidase [32].  Since we did not see any detectable level of GlcCer in caseum by 
TLC analysis, LacCer synthase may exceed the activity of SapC and β-galactosidase 
as TB granuloma progresses.  However, the relationship and roles of LacCer and SapC 
in TB pathogenesis need to be further elucidated.  
We also examined human TB granulomas to localize Mtb bacilli.  Even though 
it is not clear how the metabolism of Mtb is regulated within human TB granulomas, it 
is obvious that Mtb can survive within granulomas [33-34].  Furthermore, lipids 
identified in our study were shown to be a carbon source for Mtb during chronic 
infection [15-18, 23].  Despite the poor sensitivity of traditional methods [35-37], 
auramine-rhodamine staining detected acid fast bacilli (AFB) in nascent granulomas, 
caseous granulomas, and fibrocaseous granulomas, and the bacilli were also seen 
within caseum (Figure 4.4).  Even though the bacterial number is low, the 
amplification of the response to Mtb and its released virulence factors could explain 
the extreme tissue reaction observed in human TB granulomas.  
It is very intriguing that two different diseases, TB and atherosclerosis, share 
the same lipid species implicated in pathogenesis: CHO, CE, TAG, and LacCer [38-
39].  The accumulation of apolipoprotein-B containing lipoproteins in arterial intima 
triggers the endothelium to secrete cytokines and chemokines, thereby recruiting blood 
monocytes which differentiate into macrophages and engulf lipoproteins [40-41].  
These macrophages, namely foam cells, being full of lipid droplets, attract more  
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Figure 4.4 Localization of Mtb bacilli on human TB granulomas. 
Macrophage in nascent granuloma harbors Mtb bacillus as indicated by auramine-
rhodamine staining (A, merged with bright field).  The corresponding area is also 
shown by hematoxylin & eosin (H&E) staining (B).  Caseating granuloma harbors 
several Mtb bacilli within the caseum (C, merged with bright field), and its 
corresponding area is shown in D.  Note that B and D are mirrored images of A and C, 
respectively.  For clarity, B and D are flipped.  The arrow in red indicates Mtb bacillus.  
Some macrophages (mostly alveolar macrophages) are deposited with carbon, 
therefore presenting black dots.  Representative images are shown.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 117 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
20 µm 
 118 
 
 
Figure 4.4 (Continued) 
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monocytes, T cells, mast cells, and neutrophils to the lesion.  Smooth muscle cells 
 (SMC) are also recruited and form a fibrous cap around the necrotic, lipid-rich core.  
The rupture of the fragile lesion results in thrombosis and heart failure.  CHO and 
TAG of atherosclerotic plaques are mostly derived from low-density lipoprotein 
(LDL), and LacCer is also known to markedly accumulate in plaque intima [42] and to 
be highly excreted in urine of hypercholesterolemic patients [43].  Interestingly, our 
microarray data (Chapter 2) using caseous human pulmonary TB granulomas showed 
upregulation of genes for lipoprotein receptors including low-density lipoprotein 
receptor (LDLR), macrophage receptor with collagenous structure (MARCO), and 
macrophage scavenger receptor 1 (MSR1).  In addition to the deposition of neutral 
lipids and glycosphingolipids, the development and rupture of atherosclerotic plaque is 
strikingly similar to that of caseous human TB granuloma.   
A recent study on Mycobacterium leprae-infected lepromatous leprosy patients 
demonstrated that genes involved in lipid metabolism were highly upregulated and 
host-derived oxidized phospholipids induced by M. leprae infection modified the host 
immunity by inhibiting TLR2/1 activation [44].  Intriguingly, several of the genes 
reported as upregulated in our study (Chapter 2) overlap with those observed in 
lepromatous leprosy lesions, including ADFP and PSAP [44].  Another study showed 
increased amounts of CHO and CE in lesions of lepromatous leprosy patients [45].  
These data indicate that there are many parallels to the metabolic reprogramming 
induced by both Mtb and M. leprae.  The point at which the two infection sites diverge 
could hinge on the formation of the fibrous capsule in TB granuloma, which may 
focus and constrain the inflammatory response leading to the accumulation of the 
sequestered lipids forming the caseum.  The pathology is unique to Mtb and precedes 
the liquefaction and cavitation of the granuloma.       
 In summary, the current study showed that caseum from human TB 
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granulomas is significantly enriched with CHO, CE, TAG, and LacCer, and this 
biochemical analysis is in line with our microarray and immunohistology analyses 
(Chapter 2&3).  Due to the limited sensitivity of TLC, we cannot exclude other lipid 
species that could be important for TB granulomas.  Drug development for TB 
treatment has been focused on inhibition and/or elimination of Mtb; however, our data 
suggest that preventing lipid-laden TB granuloma from liquefying and rupturing into 
the airway space may modulate the progression of TB disease.  In analogy with 
atherosclerosis treatment, manipulation of excess inflammation, lipid accumulation, 
and lipid-mediated cell death at the localized TB granuloma may accelerate the 
treatment of TB patients receiving antibiotics.   
Future work would include identifying the origin of lipids from the caseum, 
how Mtb interfere host lipid trafficking, and finally whether lipids from foam cells are 
responsible for making up caseum.              
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CHAPTER FIVE 
MYCOBACTERIUM TUBERCULOSIS INDUCES THE FORMATION OF 
LIPID DROPLETS IN MACROPHAGES IN VITRO  
 
ABSTRACT 
Mycobacterium tuberculosis (Mtb) is transmitted via Mtb-containing aerosol droplets.  
Once inhaled, Mtb is engulfed by alveolar macrophages, which is followed by the 
recruitment of leukocytes such as monocytes, neutrophils, B-cells, and T-cells to the 
site of infection.  Mtb bacillus mainly resides in macrophages and utilizes the host 
machinery for its survival.  Our data have shown that Mtb infection leads to the 
dysregulation of host lipid metabolism as indicated by the accumulation of lipids 
within tuberculous (TB) granuloma.  Next, we examined gene regulation and protein 
expression in Mtb-infected macrophages.  Herein, we demonstrate that Mtb in vitro 
infection leads to the formation of lipid droplets in macrophages and this phenomenon 
is accompanied by upregulation of transcripts and proteins for adipose differentiation- 
related protein (ADFP), acyl-CoA synthetase long-chain family member 1 (ACSL1), 
and saposin C (SapC).  Moreover, mRNA expression of ADFP, ACSL1, and SapC can 
be reduced by mevastatin, an inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase 
(HMGCR) that blocks mevalonate and ultimately cholesterol synthesis.   
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INTRODUCTION 
Mycobacterium tuberculosis (Mtb) is phagocytosed by macrophages via 
several receptors including complement receptors (CRs), mannose receptor (MR), 
CD14, surfactant protein (SP) and type A&B scavenger receptors [1-10] and 
establishes a niche within macrophages, by circumventing phagosomal maturation, 
lysosomal fusion and acidification [11-16].  It also has been shown that Mtb enters via 
cholesterol (CHO)-enriched microdomains and CH mediates phagosomal association 
of tryptophan-alanine-rich coat protein (TACO), which prevents mycobacterial 
degradation in lysosomes [17].  Mtb-containing phagosomes retain early endosomal 
markers such as small GTPase Rab5 and exclude vesicular H
+
 ATPase from the 
vacuole, thereby maintaining the inner environment just slightly acidic at pH 6.2 [11, 
18].  These phagosomes that do not fuse with lysosomes can still interact with host 
cell recycling pathway, possibly supplying essential nutrients to intraphagosomal Mtb 
[19-20].   
Recent studies have shed light on the mechanism of Mtb survival during 
chronic infection.  As murine tuberculous (TB) granuloma progresses, lipid droplets 
accumulate as well and these organelles are in close proximity to Mtb-containing 
phagosomes, suggesting that Mtb may acquire a carbon source from lipid droplets 
[21].  Moreover, Mtb is shown to be able to degrade host-derived lipids in vitro and in 
vivo [22-25].  Our studies on human TB granulomas have revealed that the human host 
undergoes dramatic changes in lipid metabolism, and this is correlated with the 
accumulation of neutral lipids and glycosphingolipids within the granuloma in the 
form of caseum (Chapter 2&3&4).  These data combined with our earlier observation 
indicate that Mtb infection leads to lipid accumulation in the granuloma.   
In this study, we report that murine or human macrophages infected with Mtb 
accumulate lipid droplets and this phenomenon is associated with upregulation of 
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transcripts of adipose differentiation-related protein (ADFP), acyl-CoA synthetase 
long-chain family member 1 (ACSL1), and saposin C (SapC), all involved in lipid 
metabolism and lipid accumulation.  The gene expression level of ADFP, ACSL1, and 
SapC could be lowered by mevastatin that inhibits 3-hydroxy-3-methyl-glutaryl-CoA 
reductase (HMGR) of HMG-CoA pathway that produces cholesterol.  This implies 
that the host response to Mtb infection, manifested by lipid accumulation, can be 
lowered by chemicals.  
 
MATERIALS and METHODS 
Animals  
C57BL/6J mice were obtained from the Jackson Laboratory and housed under 
specific-pathogen-free conditions.  All experiments were approved by Cornell 
University Institutional Animal Care and Use Committee.  
 
Mycobacterial culture 
Mtb strain H37Rv was grown in 7H9 broth (Difco) medium supplemented with 10% 
oleic acid/albumin/dextrose/catalase (OADC) and 0.05% Tween-80.  Bacteria of 
exponential phase (O.D.600 = 0.6) were homogenized through 27G needle (BD) and 
used for macrophage infection. 
 
Culture and in vitro infection of murine macrophages 
Bone marrow cells were isolated from femurs and tibias of 6-8 week-old female 
C57BL/6J mice and cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco) 
supplemented with 20% L-929 cell-conditioned medium, 10% heat-inactivated fetal 
calf serum (HI-FCS; Hyclone), 2 mM L-glutamine (Gibco), 1 mM sodium pyruvate 
(Gibco), and 100 U/ml penicillin-100 µg/ml streptomycin (Gibco) at 37°C, 5% CO2, 
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and 90% humidity for five days.  For confocal microscopy, mature bone marrow-
derived macrophages (BMMΦ) were seeded onto coverslips (Fisher Scientific) at a 
density of 1 × 10
5
 cells per well in 24-well plates (TPP) for immunostaining or at a 
density of 1 × 10
7
 cells into 75 cm
2
 flask (TPP) for quantitative real-time RT-PCR 
analysis.  BMMΦ were incubated with Mtb H37Rv at a multiplicity of infection 20:1 
(bacteria per macrophage) for 2h, washed with PBS three times and cultured in 
DMEM medium without antibiotics.  
 
Culture and in vitro infection of human macrophages 
Monocytes were isolated from human blood (Zen-Bio Inc.) by gradient separation.  
Briefly, blood was mixed with an equal volume of PBS, and 25 ml of this mixture was 
laid over 12ml of Histopaque®-10771 (Sigma, density=1.0771 g/ml).  The mixture 
was centrifuged at 900×g for 30 min at room temperature.  The leukocytes-containing 
layer was harvested and PBS was added up to 50 ml.  Leukocytes were centrifuged at 
250 ×g for 10 min at room temperature.  This PBS wash was repeated until all the 
platelets were washed away.  Leukocytes were counted and seeded in Dulbecco’s 
Modified Eagle Medium (DMEM; Gibco) supplemented with 10% heat-inactivated 
fetal calf serum (HI-FCS; Hyclone), 2 mM L-glutamine (Gibco), 1 mM sodium 
pyruvate (Gibco), and 100 U/ml penicillin-100 µg/ml streptomycin (Gibco) at 37°C, 
5% CO2, and 90% humidity.  Medium was changed every two days, and fully 
differentiated macrophages were obtained after seven to eight days.  Macrophages 
were seeded at a density of 1 × 10
5
 cells per well in 24-well plates (TPP) for 
immunostaining (with coverslips, Fisher Scientific) or quantitative real-time RT-PCR 
analysis.  Cells were incubated with Mtb H37Rv at a multiplicity of infection 10:1 
(bacteria per macrophage) for 2h, washed with PBS three times and cultured in 
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DMEM medium without antibiotics.  For the inhibition of cholesterol synthesis, 10 
µM of Mevastatin (Sigma) was added to macrophages that were infected with Mtb.     
 
Confocal microscopy 
Cells were fixed in 4% paraformaldehyde in PBS for 30 min, washed with PBS three 
times and blocked with 5% bovine serum albumin (Sigma), 1.5% glycine (VWR 
International), and 0.1% saponin in PBS at room temperature for 1h.  Cells were 
incubated with guinea pig polyclonal antibody against murine Adfp or mouse 
monoclonal antibody against human ADFP (1:100, RDI division of Fitzgerald 
Industries Intl.), rabbit polyclonal antibody against human ACSL1 (1:200, GenWay 
Biotech), or rabbit polyclonal antibody against human SapC (1:50, Santa Cruz 
Biotechnology) at 37°C for 1 h.  After washing with PBS three times, cells were 
incubated with Texas Red®-donkey antibody against guinea pig or mouse IgG (H+L) 
(1:250, Jackson ImmunoResearch) or Texas Red®-goat antibody against rabbit IgG 
(H+L) (1:250, Jackson ImmunoResearch) and BODIPY® 493/503 (1 µg/ml, 
Invitrogen) for lipid droplets, at room temperature for 1 h.  Cells were washed with 
PBS three times, and nuclei were stained with 5 µg/ml of bisbenzimide (Sigma) in 
PBS at room temperature for 5 min.   After washing in PBS, cells were mounted in 
ProLong Gold Antifade Reagent (Molecular Probes®).  Cells without primary 
antibody staining were included as negative controls.  Images were captured using 
Leica TCS SP5 confocal laser scanning microscope (Leica Microsystems) using a 63× 
oil immersion lens.   
 
Quantitative real-time RT-PCR 
Infected and uninfected macrophages were lysed with TRIZOL
®
 Reagent (Invitrogen) 
and homogenized by passing cell lysate through a pipette.  The homogenized samples 
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were mixed with 0.2 volume of chloroform per 1 volume of TRIZOL
®
 Reagent.  The 
RNA-containing aqueous phase was column-purified using RNeasy mini kit (Qiagen).  
RNA samples were treated with DNase using TURBO DNA-free™ (Ambion).  cDNA 
was synthesized using iScript
TM
 cDNA Synthesis Kit (BIO-RAD) and used for real-
time PCR using iTaq
TM
 SYBR
®
 Green Supermix with ROX (BIO-RAD) in 7500 Fast 
Real-Time PCR System (Applied Biosystems).   
Forward and reverse primers designed by using Primer3 [26].   
The primers used in PCR for murine genes are as follows:   
Acsl1 forward, 5'-GTCCTGGGCACAGAAGAGAG-3'  
Acsl1 reverse, 5'-GTCAGAAGGCCGTTGTCAAT-3'  
Adfp forward, 5'-GGAGTGGAAGAGAAGCATCG-3' 
Adfp reverse, 5'-TGGCATGTAGTCTGGAGCTG-3' 
SapC forward, 5'-GATCCTGCCAGAACCAAGTG-3' 
SapC reverse, 5'-CTCAAGTGCCTCCACCAACT-3' 
18S rRNA forward, 5'-GCAATTATTCCCCATGAACG-3' 
18S rRNA reverse, 5'-GGCCTCACTAAACCATCCAA-3' 
The primers used in PCR for human genes are as follows: 
ACSL1 forward, 5'-CCAGAAGGGCTTCAAGACTG-3' 
ACSL1 reverse, 5'-GCCTTCTCTGGCTTGTCAAC-3' 
ADFP forward, 5'-ACTGGCTGGTAGGTCCCTTT-3' 
ADFP reverse, 5'-TGCTTCCCAATTTAGGGTTG-3' 
SapC forward, 5'-GGTGACCAAGCTGATTGACA-3' 
SapC reverse, 5'-GTACGTGTCCACCACCTCCT-3' 
18S rRNA, 5'-GATATGCTCATGTGGTGTTG-3' 
18S rRNA, 5'-AATCTTCTTCAGTCGCTCCA-3' 
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Each PCR was performed in triplicates, and PCR conditions for selected genes are as 
follows:  initial activation at 95°C for 2 min and 40 cycles of denaturation at 95°C for 
30 sec and annealing and extension at 53°C for 45 sec.  The calculated threshold cycle 
(Ct) value for each gene was normalized to Ct of house-keeping gene 18S rRNA, and 
then the fold induction of gene of interest between control macrophages and Mtb-
infected macrophages was calculated and expressed by using the formula, 2
−ΔΔCt
.   
 
RESULTS and DISCUSSION 
Macrophages not only phagocytose and digest the pathogen but also provide a 
niche for the intracellular pathogen.  Mtb has many strategies to subvert the killing 
mechanisms of the host cell, and moreover, it utilizes host-derived lipids as its own 
carbon source.  Previous studies have indicated that host cells accumulate lipids in 
response to Mtb infection [27-28].  Moreover, our microarray and immunohistology 
data (Chapter 2&3&4) indicated that caseum of human TB granulomas were abundant 
with lipids, and particularly, ADFP, ACSL1, and SapC important for lipid synthesis 
and sequestration were highly expressed in granulomas.   
In the current study, we investigated if Mtb in vitro infection in macrophages 
upregulates the same transcripts as seen in human TB granulomas; Adfp, Acsl1, and 
SapC.  We used murine bone-marrow derived macrophages (BMMΦ) and human 
peripheral blood monocyte-derived macrophages (PBMM) for Mtb infection. 
At day 1 post-infection, murine BMMΦ showed high expression levels of 
Adfp, Acsl1, and SapC (Table 5.1), which were lower at other time points.  We also 
observed Adfp, Acsl1, and SapC expressions in Mtb-infected cells by immunostaining 
on BMMΦ of day 1 post-infection (Figure 5.1A–F).  However, the antibodies against 
Adfp and SapC cross-reacted with Mtb bacilli (green Mtb bacilli can be seen in Figure 
5.1 F, arrow).   
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Table 5.1 BMMΦ genes in response to Mtb H37Rv infection 
Murine BMMФ were infected with Mtb H37Rv, and the mRNA levels of Adfp, Acsl1, 
and Psap (SapC) were determined by quantitative real-time RT-PCR.  The 
experiments were repeated at least three times, and the representative result is shown.  
Three technical replicates were included for all conditions and genes.  The fold change 
was calculated as described in the method section, and the average of replicates is 
shown.  
 
Fold induction-normalized to 18S rRNA 
Gene Day1 Day2 Day3 Day5 Day6 Day12 
Adfp 4.2 1.27 0.8 1.05 0.81 0.87 
Acsl1 26.25 3.27 2.3 1.68 1.58 0.72 
Psap 
(SapC) 
2.46 1.07 0.71 0.82 0.82 1.26 
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Figure 5.1 Expressions of Adfp, Acsl1, and SapC in murine BMMΦ are induced by 
Mtb infection. 
Murine BMMΦ were infected with Mtb H37Rv for one day and immunostained 
antigens were observed by confocal microscope. 
Representative images are shown here.  Antigens are in green and nuclei in blue.   
A. Adfp expression in control cells 
B. Adfp expression in Mtb infected cells 
C. Acsl1 expression in control cells 
D. Acsl1 expression in Mtb infected cells 
E. SapC expression in control cells 
F. SapC expression in Mtb infected cells, an arrow indicates Mtb bacillus.     
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Figure 5.1 (Continued) 
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Figure 5.1 (Continued) 
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Table 5.2 PBMM genes in response to Mtb H37Rv infection 
Human PBMM were infected with Mtb H37Rv for 4 days in the absence or presence 
of Mevastatin, and then total RNAs were prepared from three replicates.  The mRNA 
levels of ADFP, ACSLL, and PSAP (SapC) were determined by quantitative real-time 
RT-PCR.  Three technical replicates were included for all conditions and genes for the 
assay.  The fold change for each replicate was calculated as described in the method 
section, and the average of replicates is shown here. 
 
Fold induction-normalized to 18S rRNA 
Gene Mtb Mtb + Mevastatin 
ADFP 1.22 1 
ACSL1 1.86 1.63 
PSAP (SapC) 1.37 1.09 
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Figure 5.2 Expressions of ADFP, ACSL1, and SapC in PBMM are induced by Mtb 
infection 
Human PBMM were infected with Mtb H37Rv for 4 days, and immunostained 
antigens were observed by confocal microscope. 
Representative images are shown here.  Antigens are in red, neutral lipids in green, 
and nuclei in blue.     
A. ADFP expression in control cells 
B. ADFP expression in Mtb infected cells.  It is expressed at the surface of lipid 
droplets. 
C. ACSL1 expression in control cells 
D. ACSL1 expression in Mtb infected cells.  Its expression is also detected at the 
surface of lipid droplets. 
E. SapC expression in control cells 
F. SapC expression in Mtb infected cells     
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Figure 5.2 (Continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C 
D 
 142 
 
Figure 5.2 (Continued) 
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Human PBMM were infected with Mtb H37Rv for 4 days and examined for 
mRNA and protein expressions.  We observed a slight increase of transcripts in Mtb- 
infected cells (Table 5.2) and also proteins as shown by confocal microscopy (Figure 
5.2A–F).  However, the control cells also showed lipid droplets.  The addition of 
Mevastatin lowered the gene expression [29], but we could not detect any changes in 
protein expression by confocal microscopy; lipid droplets were still present (data not 
shown).   
In summary, the current study has shown that Mtb infection leads to the 
accumulation of lipid droplets in murine or human macrophages, which is 
accompanied by the upregulated transcripts and proteins of ADFP, ACSL1, and SapC.  
This data is in line with previous reports that macrophages or murine lung infected 
with virulent Mtb accumulates neutral lipids [21, 27-28, 30].  Moreover, this 
corroborates our analyses on human TB pulmonary granulomas that the host 
undergoes metabolic shift during Mtb infection which results in the accumulation of 
lipids as caseum.   
Many questions are remained unanswered.  Future work should include 
whether lipid droplets-derived lipids contribute to the formation of caseum, Mtb-
derived lipids intersect with host-derived lipids, and lipid droplets-derived lipids are 
used for Mtb survival directly or they are merely byproducts of host inflammation.  
The information about the essential carbon source for Mtb within host cells will help 
to design novel drugs. 
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CHAPTER SIX 
HOST RESPONSE TO MYCOBACTERIAL TREHALOSE DIMYCOLATE  
 
ABSTRACT 
Mycobacterium tuberculosis (Mtb) infection triggers the formation of tuberculous 
(TB) granuloma in the host.  In human TB, the mechanism of granuloma development 
and breakdown is not well-characterized.  Multiple mycobacterial cell wall 
components are shown to be responsible for the granulomatous response including 
trehalose dimycolate (TDM).  In this study, we demonstrate that macrophages in 
TDM-induced murine granulomas (TDM-granulomas) are filled with lipid droplets, 
which are associated with expression of adipose differentiation-related protein (Adfp) 
and acyl-CoA synthetase long-chain family member 1 (Acsl1).  TDM-granulomas 
secrete proinflammatory cytokines, interleukin (IL)-6 and tumor necrosis factor 
(TNF)-α, and show tissue-damaging pathology.  These phenomena are not dependent 
of B- or T-cells in mice.  Similar to human TB, microarray analysis on TDM-
granuloma reveals a striking resemblance to caseous human TB granuloma with 
regard to lipid accumulation, tissue remodeling, inflammatory response, and many 
other biological processes.  These results show that a single mycobacterial cell wall 
component, TDM, induces foam cell formation in mice and is capable of forming 
granulomas which mimic human TB granulomas.  Thus murine TDM-granulomas 
serve as a good model of human TB pathogenesis, especially regarding 
characterization of individual host factors involved in cellular recruitment, metabolic 
dysregulation, and tissue remodeling. 
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INTRODUCTION 
Mycobacterium tuberculosis (Mtb) infection results in the formation of well-
organized granuloma where the bacteria are sequestered and remain dormant unless 
tuberculosis (TB) is reactivated.  The mechanism of TB reactivation is still unclear, 
although conditions such as acquired immune deficiency syndrome (AIDS), aging, 
malnutrition, and other diseases predispose Mtb- infected individuals to active TB.  
TB transmission occurs via Mtb-containing aerosols coughed up by patients with 
active disease, when the granuloma is cavitated.  Due to limited availability of human 
TB tissues, it is prudent to develop alternative models in studying the mechanism of 
granuloma development and breakdown. 
The granulomatous response by Mtb infection has been shown to be triggered 
by Mtb cell wall components such as lipoarabinomannan (LAM), phosphatidylinositol 
mannosides (PIM), and trehalose dimycolate (TDM) [1].  Our previous work has 
shown that mycobacterial lipids are continuously released from infected cells and 
transferred to bystander cells [2-3].  Of the released lipids, TDM is a major 
immunostimulatory factor, eliciting proinflammatory cytokine production and induces 
a strong granulomatous response in mice [4-6].  We also have shown that TDM-
induced stimulation of macrophages requires the presence of toll-like receptor (TLR) 
adaptor protein myeloid differentiation factor 88 (MyD88), TLR2, CD14, and 
macrophage receptor with collagenous structure (Marco) [4, 7].  Patients with cavitary 
TB were shown to have bacteria growing on the open cavitary surface, and these 
bacilli were covered with a membrane, which might consist of TDM released from 
continuously growing bacteria at the interface between the airway and liquefactive 
granuloma [8-9].  Recently, Peyron et al. showed that TDM, particularly oxygenated 
species that are present in virulent Mtb (e.g. keto- and methoxy-mycolates) is capable 
of inducing foam cell formation in vitro [10].  This is of particular interest since foam 
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cells were seen in TB-affected lung tissues of mice and human [9-11].  Our analyses 
on human pulmonary TB granulomas also have revealed the upregulation of genes and 
proteins involved in lipid synthesis and accumulation including adipose 
differentiation-related protein (ADFP), acyl-CoA synthetase long-chain family 
member 1 (ACSL1), and saposin C (SapC), which were implicated in the formation of 
lipid-filled caseum (Chapter 2&3).  In addition, our analysis on lipid composition 
showed the abundance of neutral lipids and glycosphingolipids in caseum (Chapter 4).  
Furthermore, macrophages infected with Mtb in vitro upregulated transcripts for 
ADFP, ACSL1, and SapC (Chapter 5).  These data indicate that Mtb or Mtb-derived 
factors influence the host lipid metabolism, thereby leading to lipid accumulation.   
In this study, we examined murine TDM-induced granulomas in comparison to 
human TB granulomas.  TDM, coated onto polystyrene beads, induced a strong 
granulomatous response subcutaneously.  Numerous lipid-filled foam cells were 
observed in TDM-granuloma and lipid droplets were tightly associated with Adfp and 
Acsl1.  Ex vivo TDM-granulomas also secreted proinflammatory cytokines, e.g. IL-6 
and TNF-α.  These responses were independent on B- or T-cells, demonstrating that 
innate immunity is primarily involved in forming lipid droplets upon TDM 
stimulation.  Of special interest was to observe that murine TDM-granulomas 
presented pathologies similar to human TB granulomas.  Microarray analysis on 
TDM-granuloma further revealed similarities in gene expression profiles with regard 
to immune response, tissue remodeling, and lipid metabolism.  These results show that 
TDM provokes lipid accumulation in host cells in vivo, and therefore, TDM-
granuloma may serve as a good model to investigate human TB granuloma.           
 
METHODS and MATERIALS 
Animals  
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Four to six week-old C57BL/6J and Rag1
−/−
 (C57BL/6 background) female mice were 
obtained from the Jackson Laboratory and housed under specific-pathogen-free 
conditions.  All experiments were approved by Cornell University Institutional Animal 
Care and Use Committee. 
 
In vivo granuloma model 
Mycobacterial lipid-bearing beads were prepared as described previously, with slight 
modifications [4, 6].  Briefly, 9.25 × 10
3
 of 80 µm polystyrene microspheres (Duke 
Scientific) were coated with 15 µg of Mtb-derived TDM or control lipid 
phosphatidylglycerol (PG, Sigma) by alternative cycles of vortexing and sonication.  
The TDM- or PG-coated beads were resuspended in 300 µl of ice-cold growth-factor 
reduced Matrigel (BD).  The mixture was injected subcutaneously into the scruff of 
the murine neck.  At day 3, 6, and 9 post-inoculation, WT and KO mice were 
sacrificed and granulomas were harvested.  Three or four mice were used for the 
injection of TDM- or PG-Matrigel mixture.   
 
Histology 
Granulomas were fixed in 4% paraformaldehyde in PBS at 4°C for over 24 hours and 
transferred to 70% ethanol.  Tissues were embedded in paraffin and cut at 4 µm 
thickness (Cornell Histology Laboratory).  Sections were stained with hematoxylin & 
eosin for histological examination.   Images were captured by Zeiss Axio Imager with 
AxioVision LE software (Carl Zeiss MicroImaging).   
 
Immunohistology 
Paraffin-embedded sections were heat-fixed, deparaffinized and rehydrated.  Epitopes 
were heat-retrieved in 1 mM EDTA buffer pH 8.0, and tissue sections were blocked 
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with 5% BSA in PBS at room temperature for 1 hour.  Guinea pig polyclonal antibody 
against murine Adfp (1:200, RDI division of Fitzgerald Industrial Intl.) or rabbit 
polyclonal antibody against human ACSL1 (1:150, GenWay Biotech) was applied to 
sections at 37°C for 1 hour.  After washing with PBS three times, sections were 
incubated with 1% Sudan Black B (Sigma) in 70% ethanol at room temperature for 10 
min.  Sections were washed with PBS three times and incubated with Texas Red®-
donkey antibody against guinea pig IgG (H+L) (1:250, Jackson ImmunoResearch) or 
Texas Red®-goat antibody against rabbit IgG (H+L) (1:250, Jackson 
ImmunoResearch) at room temperature for 45 min.  After three washes with PBS, 
nuclei were stained with 5 µg/ml of bisbenzimide (Sigma) in PBS at room temperature 
for 5 min.  After thorough wash with PBS, sections were mounted in ProLong Gold 
Antifade Reagent (Molecular Probes®).  Sections without primary antibody were 
included as a negative control.  Images were captured by Zeiss Axio Imager with 
AxioVision LE software (Carl Zeiss MicroImaging).  
Cryosections were cut at 10 µm thickness and fixed in 4% paraformaldehyde in PBS 
for 20 min.  The sections were stained with BODIPY 493/503 (10 µg/ml, Invitrogen) 
or Nile Red (1 µg/ml, Sigma) for neutral lipids and with bisbenzimide for nuclei.  
Mounted sections were visualized by Zeiss Axio Imager with AxioVision LE software 
(Carl Zeiss MicroImaging).  
  
Enzyme-Linked Immunosorbent Assay 
Portions of harvested PG- or TDM-granulomas were cultured in 1ml DMEM medium 
supplemented with 10% heat-inactivated fetal calf serum (Hyclone), 2 mM L-
glutamine (Gibco), 1 mM sodium pyruvate (Gibco), and 100 U/ml penicillin-100 
µg/ml streptomycin (Gibco) at 37°C, 5% CO2, and 90% humidity for 48 hours.  
Conditioned media were collected, centrifuged to remove cell debris, and supernatants 
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were stored at −80°C until use.  Sandwich ELISAs for IL-1β, IL-6, and TNF-α were 
performed according to the manufacturer’s instructions (BD Pharmingen).   
 
Lipid analysis 
Total lipids were extracted from PG- or TDM-granulomas in chloroform:methanol 
(2:1, v/v).  The mixture was sonicated at 50°C for 1 hour and filtered through 0.2 µm-
pore size PTFE membrane (GD/X® syringe filter, Whatman).  Lipids were dried 
down under nitrogen gas.  TLC plates (Aluminum-backed Silica gel 60 plates, EMD) 
were cleaned in chloroform:methanol (90:10, v/v) and heat-activated at 110°C for 30 
min.  Total lipids were developed in chloroform:methanol:water (65:25:4) for the first 
half of the plate, and then in ether:ethyl ether: acetic acid (70:30:2, v/v/v) for the entire 
plate.  Plates were sprayed with 50% sulfuric acid in ethanol and charred for detecting 
components.  The lipid standards used were cholesteryl esters, triacylglycerols, and 
cardiolipin (Sigma), cholesterol (MP Biomedicals), and neutral glycosphingolipid 
qualmix (Matreya).     
 
Microarray 
PG- or TDM-granulomas were lysed with TRIZOL® Reagent (Invitrogen) and 
homogenized by passing the lysate through a pipette.  The homogenized samples were 
mixed with 0.2 volume of chloroform per 1 volume of TRIZOL, and phases were 
separated by centrifugation at 12,000 × g for 15 min at 4°C.  The RNA-containing 
aqueous phase was column-purified using RNeasy mini kit (Qiagen), according to 
manufacturer’s instructions.  RNA samples were treated with DNase using TURBO 
DNA-free® (Ambion).  Purity, quality, and quantity of RNA were assessed by the 
Agilent NanoChip Bioanalyzer assay, spectrophotometric analysis, and reverse-
transcription PCR of β-actin (157 bp), 18S rRNA (123 bp), and glyceraldehyde-3-
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phosphate dehydrogenase (189 bp).  Because PG does not recruit many leukocytes to 
the PG injection site, harvested RNA was not sufficient for performing microarrays.  
Therefore, total RNA samples from both PG- and TDM-granulomas were subjected to 
amplification.  Two-rounds of linear amplification using RiboAmp HS
TM
 
Amplification Kit (Molecular Devices) generated sufficient RNA.  The amplified 
antisense RNA (aRNA) was biotinylated using BioArray High Yield
TM
 RNA 
Transcript Labeling Kit (T7) (Enzo Life Sciences, Inc.), followed by fragmentation, 
hybridization onto GeneChip® Mouse Genome 430 2.0 Array (Affymetrix) and 
scanning by GeneArray 300 Scanner (Affymetrix).  More than three biological 
replicates were performed for PG- or TDM-induced granulomas. 
 
Microarray Data Analysis  
The data were analyzed by using GeneSpring GX 10.0.2 program (Agilent 
Technologies).  Briefly, MAS5 method was used to summarize raw CEL files, the 
normalization was done by scaling to median of all samples and the baseline was 
transformed to the median of all samples.  Further analysis was done using Ingenuity 
Pathway Analysis (Ingenuity® Systems, www.ingenuity.com).   
 
Statistical analysis 
The statistical significance of differences in gene expressions between PG-granuloma 
and TDM-granuloma was calculated using an unpaired t test.  Results with P value 
less than 0.05 were considered statistically significant.   
 
RESULTS and DISCUSSION 
In TB patients, Mtb bacilli are maintained in a well-established structure, TB 
granuloma.  Most Mtb-infected individuals control this granuloma during life time 
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without showing any clinical symptoms, whereas immunocompromised individuals 
develop active disease accompanied by granuloma breakdown.  We have shown that 
human pulmonary TB granulomas undergo a metabolic shift during active TB disease, 
with upregulated lipid metabolism and lipid accumulation in the form of caseum 
(Chapter 2&3&4).  Moreover, Mtb in vitro infection leads to lipid accumulation in 
macrophages (Chapter 5).   
In the current study, we examined the granuloma formation in mice using 
TDM.  When TDM was injected into mice subcutaneously, it recruited numerous 
leukocytes to the site of injection.  TDM induced a strong granulomatous response as 
opposed to control lipid PG (Figure 6.1 A&B).  Interestingly, foam cells were 
frequently observed around TDM-bearing beads (Figure 6.2 A).  In contrast, control 
lipid PG-bearing beads recruited barely any cells (Figure 6.3 A).  The extent of foam 
cell formation was higher at later time points, indicating lipid accumulation occurs 
progressively (data not shown).  Foam cells in TDM-granulomas expressed lipid 
droplet-associated protein, Adfp (Figure 6.2 B), and lipid droplets were observed by 
neutral lipid staining with Nile Red on cryosections (Figure 6.2 C).  PG-granuloma 
does not have any detectable Adfp expression (Figure 6.3 B).   
To examine if the foam cell formation in response to TDM is dependent on 
cells of acquired immune response, we injected TDM-bearing beads into Rag1
−/−
 
(KO) mice that do not have B- and T-cells.  KO mice developed a granulomatous 
response similar to wild-type (WT) mice (Figure 6.4 A).  Cells surrounding TDM-
beads in KO mice also foamy and express Adfp alongside (Figure 6.4 B).  On the 
contrary to TDM-granulomas, PG-granulomas from KO mice did not recruit many 
leukocytes and Adfp was not detectable (Figure 6.5 A&B).  These data suggest that 
innate immunity is sufficient for the lipid droplet formation in response to TDM in our 
granuloma model.  
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Figure 6.1 The gross feature of PG- and TDM-induced granulomas at day 6. 
PG-granuloma is pale (A), whereas TDM-granuloma is well vascularized and 
capsulated (B).  
 
A 
B 
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Figure 6.2 TDM induces foam cell formation in mice.   
Cells around TDM-beads are foamy, filled with lipid droplets (A).  The arrow 
indicates a foam cell.  Foam cells are accompanied by lipid droplet-associated protein, 
Adfp (B).  Adfp is in red and nuclei in blue.  The presence of lipid droplets (green) is 
detected by staining with Nile Red for neutral lipids (C).   
Granulomas were harvested at day 6.   
 
A 
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Figure 6.2 (Continued) 
C 
B 
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Figure 6.3 PG does not induce a strong granulomatous response. 
PG-beads have a few recruited cells (A).  Cells around PG-beads show weak Adfp 
expression (B).  Adfp is in red and nuclei in blue.   
Granulomas were harvested at day 6.   
 
B 
A 
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Figure 6.4 TDM induces foam cell formation in Rag1
−/−
 mice.   
Cells around TDM-beads are foamy, filled with lipid droplets (A).  The arrow 
indicates foam cells.  Foam cells are accompanied by lipid droplet-associated protein, 
Adfp (B).  Adfp is in red and nuclei in blue.  Granulomas were harvested at day 6.   
 
 
 
 
A 
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Figure 6.4 (Continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
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Figure 6.5 PG-induced response in Rag1
−/−
 mice.   
PG recruited a few cells (A) and Adfp is not detectable (B).  Adfp is in red and nuclei 
in blue.  Granulomas were harvested at day 6.   
 
 
A 
B 
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As we observed upregulated transcripts for Adfp, Acsl1, and SapC in Mtb-
infected macrophages (Chapter 5), we examined the expression of Acsl1 and SapC in 
TDM-granulomas.  Only Acsl1 was detected by immunohistology (Figure 6.6).   
Previous work in our laboratory has shown that ex vivo TDM-granuloma 
secrete proinflammatory cytokines [4, 6].  Since the histology of WT and KO mice 
was similar, we compared cytokine production in WT and KO TDM granulomas.  
There were no statistically significant differences in IL-6 and TNF-α production 
between WT and KO TDM granulomas (Figure 6.7).  Although we cannot exclude the 
role of lymphocytes or lymphocyte-derived factors in regulating the host response to 
TDM, our data propose that the accumulation of lipids in response to a mycobacterial 
lipid is driven mainly by innate immunity. 
In addition to lipid accumulation in TDM-granulomas, we also observed tissue 
degeneration and necrotizing center, which are strikingly similar to caseous necrosis in 
human TB granulomas (Figure 6.8).  For further investigation, we performed 
microarray analysis on TDM-granulomas to examine gene regulation.  About 74% of 
oligonucleotide probe sets that were differentially expressed in murine TDM-
granulomas (P < 0.05) overlapped with those that were differentially expressed in 
caseous human pulmonary TB granulomas; totally 4757 genes are common to both 
murine TDM-granulomas and human TB granulomas (P < 0.05) (Figure 6.9).  
Ingenuity Pathway Analysis® of 4757 common genes showed top bio functions 
occurring in both murine-TDM granulomas and human TB granulomas including 
inflammatory response, cell death, cellular movement, and tissue morphology (Table 
6.1).  Moreover, many biological processes were significantly upregulated in murine 
TDM-granulomas as observed in human TB granulomas, e.g. immune response, tissue 
remodeling, and lipid metabolism (Table 6.2–6.4).  Consistent with Adfp and Acsl1 
protein expressions in TDM-granulomas as shown by immunohistology (Figure 6.2& 
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Figure 6.6 TDM-granulomas express Acsl1.  
Cells surrounding TDM-bearing beads express lipid synthesis-associated protein, 
Acsl1.  Acsl1 is in red and nuclei in blue.  Granulomas from WT mice were harvested 
at day 6.   
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Figure 6.7 Ex vivo TDM-granulomas from WT and KO (Rag1
−/−
) mice produce 
comparable amounts of proinflammatory cytokines.  Levels of IL-6 and TNF-α were 
measured by Enzyme-Linked Immunosorbent Assay (ELISA).  Data from 3 mice are 
shown as mean ± S.D.   
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Figure 6.8 The pathology of murine TDM-granuloma is similar to that of caseous 
human TB granuloma.  TDM-granuloma (A) shows tissue degeneration in a similar 
way to the caseation in human TB granuloma (B, caseous center, caseum).   
A 
B 
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Figure 6.9 Differentially expressed genes in murine TDM-granulomas overlap with 
those in caseous human pulmonary TB granulomas.  Totally, 4757 genes represent 
9886 probes that overlap between TDM-granulomas and TB granulomas.  Probes from 
TDM-granulomas are in red and probes from human TB granulomas in blue.  P < 0.05  
Mouse Genome 430 2.0 GeneChip contains 45,000 probes for 39,000 transcripts. 
Human X3P GeneChip contains 61,000 probes for 47,000 transcripts.   
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Table 6.1 Top Biological Functions common to both Murine TDM-Granulomas and 
Caseous Human Pulmonary TB Granulomas.  The microarray data were analyzed by 
using Ingenuity Pathway Analysis®.    
 
Diseases and Disorders 
Name p-value No. of molecules 
Inflammatory Response 2.97
−16–5.92−7 541 
Inflammatory Disease 3.69
−19–6.01−7 1002 
Cancer 2.25
−20–5.56−7 1267 
Neurological Disease 2.97
−20–1.28−7 1379 
Hematological Disease 6.22
−22–6.08−7 435 
Molecular and Cellular Functions 
Name p-value No. of molecules 
Cell death 2.74
−48–5.08−7 1135 
Cellular growth and proliferation 1.61
−26–5.68−7 1126 
Cellular Development 2.04
−26–5.58−7 920 
Cellular Movement 4.18
−26–4.46−7 661 
Cellular Function and Maintenance 2.35
−20–4.46−7 426 
Physiological System Development and Function 
Name p-value No. of molecules 
Organismal Survival 9.72
−27–6.62−13 484 
Hematological System Development and Function 3.67
−24–5.55−7 661 
Hematopoiesis 3.67
−24–2.27−7 391 
Tissue Morphology 3.06
−19–5.96−7 422 
Cell-Mediated Immune Response 9.40
−19–2.27−7 285 
Top Canonical Pathways 
Name p-value Ratio 
Receptor Activator of Nuclear Factor-Kappa B Signaling in Osteoclasts 1.2
−13
 56/96 (0.583) 
Interleukin-10 Signaling 1.69
−13
 42/70 (0.614) 
Role of Protein Kinase R in Interferon Induction and Antiviral Response 1.36
−12
 32/46 (0.696) 
B cell Receptor Signaling 2.41
−12
 76/154 (0.494) 
Induction of Apoptosis by Human Immunodeficiency Virus 1 2.01
−11
 40/65 (0.615) 
Top  Toxicity Lists 
Name p-value Ratio 
Nuclear Factor-Kappa B signaling Pathway 1.34
−10
 61/112 (0.545) 
Retinoic Acid Receptor Activation 5.76
−7
 61/133 (0.459) 
Mechanism of Gene Regulation by Peroxisome Proliferators via 
Peroxisome Proliferator-Activated Receptor Alpha 
7.79
−7
 47/95 (0.495) 
Hepatic Cholestasis 2.57
−6
 60/135 (0.444) 
Hepatic Fibrosis 3.09
−6
 42/85 (0.494) 
 
 
 169 
 
 
 
 
 
 
 
Table 6.2 Murine TDM-granulomas show upregulated transcripts for immune 
response.  These genes are also upregulated in caseous human pulmonary TB 
granulomas (P < 0.05).    
 
Cluster of Differentiation molecules 
Gene Description Fold change Gene Description Fold change 
Cd14 CD14 molecule 9.6 Cd53 CD53 molecule 1.9 
Cd33 CD33 molecule 3.7 Cd80 CD80 molecule 4.7 
Cd44 CD44 molecule 3.3 Cd86 CD86 molecule 2.3 
Major Histocompatibility Complex molecules 
Gene Description Fold change Gene Description Fold change 
H2-D1 Histocompatibility 2, D 
region locus 1 
1.7 H2-Q7 Histocompatibility 
2, Q region locus 7 
2.2 
H2-L Histocompatibility 2, D 
region 
1.7 H2-Q8 Histocompatibility 
2, Q region locus 8 
2.7 
Receptors/Antigen recognition 
Gene Description Fold change Gene Description Fold change 
C5ar1 Complement component 
5a receptor 1 
2.7 Msr1 Macrophage scavenger  
receptor 1 
2.2 
Fcer1g Fc fragment of IgE, high 
affinity I, receptor for; 
gamma polypeptide 
1.6 Scarb1 Scavenger receptor 
class B, member 1 
2.1 
Fcgr2b  Fc receptor, IgG, low 
affinity, IIb 
1.9 Scarb2 Scavenger receptor 
class B, member 2 
2.1 
Marco Macrophage receptor with 
collagenous structure 
34.2 Tlr2 Toll-like receptor 2 5.9 
Tlr4 Toll-like receptor 4 1.9 
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Table 6.2 (Continued) 
Cytokines and cytokine receptors 
Gene Description Fold 
change 
Gene Description Fold 
change 
Csf1 Colony stimulating factor 1 2.5 Ltb Lymphotoxin B 8.4 
Fas Fas  11.7 Tnfaip2 TNF, alpha-induced protein 
2 
4.4 
Il1b Interleukin 1, beta 110.1 TnfaipP3 TNF, alpha-induced protein 
3 
5.9 
Il13ra1 Interleukin 13 receptor, 
alpha 1 
2.7 Tnfrsf1a TNF receptor superfamily, 
member 1A 
1.5 
Il15 Interleukin 15 1.6 Tnfrsf1b TNF superfamily, member 
1B 
2.5 
Il15ra Interleukin 15 receptor, 
alpha 
1.7 Tnfrsf21 TNF receptor superfamily, 
member 21 
1.4 
Il17ra Interleukin 17, receptor A 2.6 Tnfsf10 TNF (ligand) superfamily, 
member 10 
2.4 
Chemokines and chemokine receptors 
Gene Description Fold 
change 
Gene Description Fold 
change 
Ccl3 Chemokine (C-C motif) 
ligand 3 
46.3 Cmklr1 Chemokine-like receptor 1 1.2 
Ccl4 Chemokine (C-C motif) 
ligand 4 
39.1 Cxcl11 Chemokine (C-X-C motif) 
ligand 1 
17.2 
Ccr1 Chemokine (C-C motif) 
receptor 1 
6.0 Cxcl2 Chemokine (C-X-C motif) 
ligand 2 
38.7 
Ccr7 Chemokine (C-C motif) 
receptor 7 
2.1 Cxcl12 Chemokine (C-X-C motif) 
ligand 12 
8.4 
Ccrl2 Chemokine (C-C motif) 
receptor-like 2 
11.9 Cxcl16 Chemokine (C-X-C motif) 
ligand 16 
2.2 
Cklf Chemokine-like factor 1.5 Cxcr4 Chemokine (C-X-C motif) 
receptor 4 
7.1 
Signaling 
Gene Description Fold 
change 
Gene Description Fold 
change 
Inhba Inhibin, beta A 4.6 Pag1 Phosphoprotein associated 
with glycosphingolipid 
microdomains 1 
3.6 
Irak Interleukin-1 receptor-
associated kinase 2 
4.3 Smad3 MAD homolog 3 2.9 
Irak3 Interleukin-1 receptor-
associated kinase 3 
3.9 Stat6 Signal transducer and activator 
of transcription 6,  
1.5 
Map3k5 Mitogen-activated protein 
kinase kinase kinase 5 
2.1 Syk Spleen tyrosine kinase 7.3 
Mapk1 Mitogen-activated protein 
kinase 1 
1.3 Traf1 TNF receptor- associated 
factor 1 
3.9 
Msn Moesin 1.8 Traf3 TNF receptor-associated 
factor 3 
3.2 
Myd88 Myeloid differentiation 
primary response gene 88 
1.6 Tnip3 TNFAIP3 interacting protein 3 25.4 
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Table 6.3 Murine TDM-granulomas show upregulated transcripts for angiogenesis 
and tissue remodeling.  These genes are also upregulated in caseous human pulmonary 
TB granulomas (P < 0.05).    
 
Proteolysis 
Gene Description Fold 
change 
Gene Description Fold 
change 
Casp4 Caspase 4 3.5 Mmp9 Matrix 
metallopeptidase 9 
21.6 
Casp6 Caspase 6 1.8 Mmp10 Matrix 
metallopeptidase 10 
186.5 
Casp8 Caspase 8 1.5 Serpinb9 Serpin peptidase 
inhibitor, clade B, 
member 9 
1.3 
Chi3l1 Chitinase-3-like 1 48.6 Timp1 Tissue inhibitor of 
metalloproteinase 1 
1.3 
Fibrosis 
Gene Description Fold 
change 
Gene Description Fold 
change 
Col3a1 Collagen, type III, alpha 1 1.7 Col18a1 Collagen, type XVIII, 
alpha 1 
4.6 
Col4a1 Collagen, type IV, alpha 1 7.2 Col24a1 Collagen, type XXIV, 
alpha 1 
1.5 
Col4a3bp Collagen, type I, alpha 1, 
alpha 3 binding protein 
2.4 
Itga5 Integrin, alpha 5 2.6 
Angiogenesis 
Gene Description Fold 
change 
Gene Description Fold 
change 
Hif1a Hypoxia inducible factor 1, 
alpha subunit 
17.8 Pdgfrb Platelet derived growth 
factor receptor, beta 
polypeptide 
2.3 
Pdgfra Platelet derived growth factor 
receptor, alpha polypeptide 
1.4 Vcan Versican 3.8 
Vegfa Vascular endothelial 
growth factor A 
1.5 
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6.6), the transcripts were also upregulated (Table 6.4).  Moreover, among genes 
involved in inflammation, Cd14, Marco, and Tlr2 were upregulated, which is line with 
our previous report on the macrophage response to TDM (Table 6.2) [7].    
The lipid analysis indicated that TDM-granulomas have more cholesterol 
(CHO), cholesteryl esters (CE), and triacylglycerols (TAG), and different 
compositions of glycosphingolipids and phospholipids, compared to PG-granuloma 
(Figure 6.10).  As lipid droplets are mainly composed of sequestered CHO or CE and 
TAG, this data is consistent with the histology and microarray analyses on TDM-
granulomas.          
The formation and development of TB granulomas is a result of the complex 
relationship between host and Mtb bacilli.  Since both host and bacterial factors 
contribute to this process, it is difficult to pin down one single component that is 
responsible for TB granuloma development.  Our results herein provide a different 
avenue to examine human TB pathogenesis.  TDM, a mycobacterial cell wall lipid, 
has shown to induce lipid droplets in vitro [10, 12] and it is true in our in vivo 
granuloma model.  The formation of lipid droplets is not dependent of B- or T-cells, 
implying that the major host driver for this process is innate immunity.  Moreover, 
gene regulation in TDM-granulomas revealed a considerable overlap with that in 
caseous human pulmonary TB granulomas.  We hypothesize that Mtb (or mainly 
TDM)-induced lipid droplets contribute to the formation of caseum within the 
confined granuloma structure, in analogy with the caseum formation in human TB 
granuloma.  In addition to lipid accumulation in TDM-granulomas, tissue remodeling 
and degeneration was also prominent, similarly to human TB granulomas.  Our 
granuloma model can be used to study essential processes involved human TB 
granuloma development. 
Further investigations into the dynamic biology of the TB granuloma are 
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Table 6.4 Murine TDM-granulomas show upregulated transcripts for lipid 
metabolism.  These genes are also upregulated in caseous human pulmonary TB 
granulomas (P < 0.05).  
 
Lipid synthesis and sequestration 
Gene Description Fold 
change 
Gene Description Fold 
change 
Abhd5 Abhydrolase domain 
containing 5 
1.6 Degs1 Degenerative spermatocyte 
homolog 1, lipid desaturase 
1.4 
Gba Glucosidase, beta, acid 1.4 
Acly ATP citrate lyase 1.2 Gla Galactosidase, alpha 1.7 
Acsl1 Acyl CoA synthetase long 
chain family member 1 
8.1 Gpd2 Glycerol phosphate 
dehydrogenase 2, mitochondrial 
1.9 
Acsl4 Acyl CoA synthetase long 
chain family member 4 
2.3 Plscr1 Phospholipid scramblase 1 1.5 
Adfp Adipose differentiation-
related protein 
2.0 Soa1 Sterol O-acyltransferase 1 1.6 
Cyp1b1 Cytochrome P450, family 
1, subfamily B, 
polypeptide 1 
3.7 Tpi1 Triosephosphate isomerase 1 1.7 
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Figure 6.10 Lipid analysis of PG- and TDM-granulomas 
Total lipids from PG-granuloma (4, day 6;  5, day 9;  6, day 9 surrounding adipose 
tissue and capsule) and TDM-granuloma (7, day 6;  8, day 9;  9, day 9 surrounding 
adipose tissue and capsule) were extracted from granulomas and separated by thin-
layer chromatography, together with standard lipids, oleic acid (1), cardiolipin (2), 
neutral glycosphingolipids (3), cholesteryl esters (CE) (10), cholesterol (CHO) (11), 
and triacylglycerol (TAG) (l2).  More than three biological replicates per time point 
(day 6 and 9) were analyzed and representative lipid samples are shown.        
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imperative.  Studies on the characterization of individual host molecules important in 
lipid accumulation and of minor lipid species involved in inflammatory response will 
help to advance our knowledge on human TB granuloma development.    
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CHAPTER SEVEN 
CONCLUSIONS 
 
Summary 
One third of the world population is infected with Mycobacterium tuberculosis 
(Mtb); most of infected individuals do not develop active disease, which is known as 
chronic or latent infection (or latency).  Healthy individuals control Mtb infection by 
forming a tightly structured granuloma, which is made of leukocytes forming a core 
around Mtb-infected cells and the fibrous capsule at the periphery.  Tuberculous (TB) 
granuloma protects the host by confining the infection at the local foci but also serves 
as a niche for Mtb protected from the host immune system.  During active TB disease, 
granulomas liquefy and cavitate, and at this stage Mtb bacilli start to multiply 
exponentially.  The transition of latency to active TB disease and transmission is 
preceded by the enlargement and liquefaction of caseum (caseous center) and the 
breakdown of fibrous capsule.  Despite the importance of this process, we do not fully 
understand how gene expression is regulated within TB granulomas, how the caseum 
develops, and what makes up the caseum.     
The work was initiated to advance our knowledge on the biology of TB 
granulomas by using human TB tissues and in vitro and in vivo model systems.   
Chapter two detailed the microarray analysis on caseous human pulmonary TB 
granulomas.  We used ‘caseous’ ‘pulmonary’ granulomas for our study since the 
development of caseum precedes the liquefaction and erosion of granulomas and the 
transmission mainly occurs in pulmonary TB.  The microarray data analysis of 
caseous human pulmonary TB granulomas has generated biological pathways beyond 
immunological processes (Table 2.1–2.4): e.g. angiogenesis, apoptosis, lipid 
metabolism, oxidative stress, and tissue remodeling.  Previous studies [1-2] 
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demonstrated the abundance of lipid-filled foam cells in human TB lung tissues and 
our microarray data also indicated that genes involved in lipid metabolism are highly 
upregulated in caseous human pulmonary TB granulomas (Table 2.4).  These data 
suggest that Mtb infection leads to the upregulation of genes involved in lipid 
synthesis and sequestration within TB granulomas, thereby forming foam cells and 
ultimately caseum.  
To further understand the lipid metabolism implicated in human TB 
granulomas, in Chapter three, we examined the expression of selected proteins 
involved in lipid synthesis and sequestration by immunohistological analysis of human 
TB lung tissues; adipose differentiation-related protein (ADFP), acyl-CoA long chain 
family member 1 (ACSL1), and saposin C (SapC) that represent three different 
pathways of lipid metabolism were chosen for the analysis (Figure 2.2 and Table 2.4).  
Strikingly disproportionate expression of ADFP, ACSL1, and SapC was observed 
(Figure 3.2–3.4), which was accompanied by the formation of lipid droplet-filled foam 
cells in caseous granulomas and inflamed respiratory bronchioles (Figure 3.5).  The 
high expression of ADFP, ACSL1, and SapC together with the observation of lipid 
droplets implies that lipid synthesis and accumulation are upregulated within caseous 
human pulmonary TB granulomas.   
Biochemical analysis showed that the caseum of TB granulomas was 
significantly enriched with neutral lipids, especially, cholesterol (CHO), cholesteryl 
esters (CE), triacylglycerols (TAG), and glycosphingolipid lactosylceramide (LacCer) 
(Figure 4.1–4.3).  This finding is very interesting since the accumulation of neutral 
lipids is facilitated by ACSL1 and ADFP activity and that SapC is implicated in 
LacCer metabolism.  Together, these biochemical (Chapter four), transcriptional 
(Chapter two), and immunohistological (Chapter three) data support our hypothesis 
that lipids accumulate within human TB granulomas, forming a caseum, and this 
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process is accompanied by the upregulation of genes and proteins involved in lipid 
synthesis and sequestration.  In analogy to atherosclerosis, the accumulated lipids 
within TB granulomas may exacerbate inflammation and make the center of TB 
granulomas more necrotic, which leads to the rupture of granulomas into airways.  
These lipids within necrotic caseum that is isolated from host immune system may 
promote Mtb survival by providing carbon source.  
In Chapter five, we examined the effect of Mtb on macrophages in vitro.  Mtb-
infected murine or human macrophages showed upregulation of the same transcripts 
as seen in human TB granulomas: ADFP, ACSL1, and PSAP (SapC) (Table 5.1&5.2).  
By using confocal microscopy, we could detect foam cells accompanied with ADFP, 
ACSL1, and SapC expression in Mtb-infected cells (Figure 5.1&5.2).  These data 
indicate that Mtb infection induces lipid accumulation within host cells.  
Our data (Chapter two–five) showed that lipids accumulate within human TB 
granulomas and that Mtb affects the host lipid metabolism in vitro.  To examine this 
process in vivo, we used our granuloma model [3] in Chapter six.  As demonstrated, 
the Mtb cell wall lipid, trehalose dimycolate (TDM), induced a strong granulomatous 
response and foam cell formation in mice (Figure 6.1&6.2).  This phenomenon was 
not dependent on the presence of B- or T-cells (Figure 6.4), indicating that innate 
immune cells are mainly involved in the formation of foam cells.  In addition to lipid 
accumulation, TDM-induced granulomas showed a striking similarity to human TB 
granulomas as shown by histology and microarray analyses (Figure 6.8&6.9 and Table 
6.1–6.4).  Therefore, by using our TDM granuloma model, we can explore 
mechanisms implicated in human TB pathogenesis.  For example; (1) host signaling 
molecules involved in lipid droplet formation can be investigated by using knockout 
mice or pharmacological agents, (2) lipid trafficking within live cells can be examined 
by confocal imaging, (3) identification of inflammatory lipid species that are common 
 182 
 
to TDM granuloma and human TB granuloma, (4) elucidation of cell death pathway 
that leads to the formation of  necrotic, caseous center, (5) fibrosis in TDM 
granulomas can be manipulated pharmacologically or genetically (e.g. targeting 
plasminogen activator inhibitor-1), and (6) tissue degradation can be modulated by 
agents such as matrix metalloproteinase inhibitors.  The use of murine models to 
answer questions emerging from human data represents the best of both systems.     
Whether Mtb multiplies or remains dormant within human TB granulomas 
during latency is not clear.  Yet, Mtb bacilli survive within granulomas during latency, 
and they multiply and escape from cavitated granulomas during active TB disease.  
The bacilli require energy to survive during latency; however, the carbon source 
within human granulomas is not known.  The accumulated neutral lipids in the caseum 
of human TB granulomas identified in the current study (Chapter four) could serve as 
a carbon source for Mtb.  Recently, in vitro and in vivo studies demonstrated the 
capability of Mtb to metabolize CHO [4-7].  However, it should be cautioned that 
murine TB granulomas do not develop the caseum as seen in human TB granulomas.  
Therefore, the nature of CHO requirement for Mtb survival within murine granulomas 
may differ from human granulomas.  Our in vitro and in vivo studies (Chapter five and 
six) suggest that Mtb infection induces foam cell formation.  Neutral lipids and 
glycosphingolipids sequestered in the caseum are most likely to be derived from host 
cells.  Especially, lipid droplets released from foam cells (rather than other leukocytes) 
within TB granulomas are likely to be the main source of lipids accumulated in the 
caseum.  Further investigation is necessary to determine if lipids released from foam 
cells make up the same lipid species identified within the caseum.  In addition, the 
caseum may contain minor lipid species (inflammatory lipids such as prostaglandins 
and leukotrienes) that might play a role in TB pathogenesis.   
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Even though the caseum increases in size, Mtb bacilli are not likely to be 
released from the lesion unless the fibrous capsule breaks down; however, the factors 
that drive capsule breakdown are not known.  Dannenberg et al. have shown that 
cathepsin D activity is upregulated in macrophages in Mycobacterium bovis-infected 
rabbits and proposed that the proteinase activity of cathepsin D may be responsible for 
the liquefaction of caseum and the subsequent cavitation [8].  Our microarray analysis 
on murine TDM-granulomas (Chapter six) showed that the expression of cathepsin D 
transcript was 1.4 fold upregulated compared to control PG-granulomas.  Moreover, 
cathepsin D protein was strongly expressed in murine TDM-granulomas as shown by 
immunohistology (Figure 7.1A), which was not dependent on the presence of B- or T-
cells (TDM-granulomas from Rag1
−/−
 mice, Figure 7.1B).  This phenomenon is 
interesting in that the death and degradation of macrophages within TB granulomas is 
thought to mainly contribute to the formation of caseum.  Caseous human pulmonary 
TB granulomas did not show statistical significance in the upregulation of cathepsin D 
transcript (Chapter two, 4.9 fold upregulation); however, many genes involved in 
tissue degradation and remodeling were highly upregulated (Table 2.3).  Chitinase 3-
like-1 (CHI3L1) is of particular interest.  CHI3L1, a 40 kDa glycoprotein, is involved 
in tissue remodeling and angiogenesis and is highly secreted in human cancers such as 
lung, breast, colon, liver, prostate, ovaries, brain, and thyroid cancer [9].  CHI3L1 is 
also implicated in inflammatory diseases including rheumatoid arthritis, liver fibrosis, 
bacterial septicemia, and inflammatory bowel disease [9].  It is worth investigating the 
level of CHI3L1 in bronchoalveolar lavage fluid or serum of TB patients; it may be 
used as a severe TB disease marker.  The activity of enzymes such as matrix 
metallopeptidases, caspases, and urokinase can be tested on human TB granulomas 
and murine TDM-granulomas, by using in situ zymography.  Mice that lack genes 
involved in fibrosis, angiogenesis, or tissue degradation (e.g. fibulin, collagen,  
 184 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 Cathepsin D is strongly expressed in murine trehalose dimycolate- induced 
granulomas.  At day 6 of post-inoculation, granulomas were harvested from wild-type 
(A) and Rag1
−/−
 (B) mice and tissue sections were probed with antibody against 
cathepsin D.  Immunofluorescence was performed as described in Chapter six. 
A 
B 
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integrin, connective tissue growth factor, matrix metallopeptidase, serpin peptidase 
inhibitor, CHI3L1, and vascular endothelial growth factor A) can be used to study 
tissue remodeling and granuloma breakdown, in our TDM granuloma model.  By 
using models such as rabbits or non-human primates, pharmacological agents or small 
interfering RNA that block enzymatic activities can be administered to see if excess 
caseation and liquefaction, and following breakdown can be modulated.     
 
Ongoing studies 
The formation of caseum within TB granulomas is believed to result from the 
death of cells, mainly macrophages; nonetheless, the mechanism of cell death in TB 
pathogenesis is not well-characterized.  In addition, it is not clear if cell death benefits 
the host and/or the Mtb bacillus.  Whether endoplasmic reticulum (ER) stress-induced 
apoptosis is involved in TB pathogenesis is not known (Figure 7.2); our microarray 
analysis on caseous human pulmonary TB granulomas (Chapter two) revealed that 
genes involved in ER stress were highly upregulated (Table 7.1).  Furthermore, Mtb 
infection leads to the upregulation of transcripts for ER stress in murine macrophages 
(Table 7.2).  We also observed increased expression of CCAAT/enhancer-binding 
protein homologous protein (CHOP) and cytochrome c somatic (CYCS) in caseous 
human TB granulomas (Figure 7.3 A&B), and 80–90% of CHOP-positive cells were 
positive with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
staining (data not shown).  These data indicate that ER stress or ER stress-induced 
apoptosis is implicated in TB pathogenesis.  We are currently preparing a manuscript 
(Induction of ER stress in macrophages of tuberculosis granulomas; Seimon TA, Kim 
MJ, Blumenthal A, Koo J, Wainwright H, Kaplan G, Bekker LG, Ehrt S, Nathan C, 
Tabas I, and Russell DG, submitted to PLoS ONE).   
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Figure 7.2 Endoplasmic reticulum stress and cell death in tuberculosis pathogenesis 
The mechanism of cell death in tuberculous granulomas is not well-characterized.  
This simplified diagram shows some of the key molecules that are involved in 
endoplasmic reticulum (ER) stress and subsequent cell death.    
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Table 7.1 Genes relevant for ER stress response are highly upregulated in caseous 
human pulmonary TB granulomas (P < 0.05).  The microarray data analysis is 
described in Chapter two. 
 
Endoplasmic Reticulum (ER) Stress Response 
Gene Description 
Fold 
upregulation 
APAF1 Apoptotic peptidase activating factor 1 9.0 
ATF2 Activating transcription factor 2 20.1 
ATF6 Activating transcription factor 6 33.8 
CALR Calreticulin 13.3 
CANX Calnexin 16.9 
CASP1 
CASP3 
Caspase 1, apoptosis-related cysteine peptidase 35.7 
Caspase 3, apoptosis-related cysteine peptidase 63.7 
CASP4 Caspase 4, apoptosis-related cysteine peptidase 91.7 
CASP8 Caspase 8, apoptosis-related cysteine peptidase 114.7 
CASP9 Caspase 9, apoptosis-related cysteine peptidase 16.0 
CYCS Cytochrome C, somatic 61.2 
DDIT3/CHOP DNA-damage-inducible transcript 3 20.0 
EDEM1 ER degradation enhancer, mannosidase alpha-like 1 8.0 
ERO1L Endoplasmic oxidoreductin-1-like protein 54.7 
HERPUD1 Homocysteine-inducible, ER stress-inducible, 
ubiquitin-like domain member 1 
43.0 
HSP90B1 Heat shock protein 90 kDa beta (Grp94), member 1 72.6 
PDIA4 Protein disulfide isomerase family A, member 4 80.3 
TRAF2 TNF receptor associated factor 2 14.7 
XBP1 X-box binding protein 1 22.5 
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Table 7.2 Genes relevant for ER stress response are upregulated in Mtb-infected 
murine macrophages.  The quantitative real-time RT-PCR was performed as described 
in Chapter five.  The experiments were repeated at least three times, and the 
representative result is shown.  Three technical replicates were included for all 
conditions and genes.  The fold change was calculated as described in the method 
section (Chapter five), and the average of replicates is shown.  
 
Endoplasmic Reticulum (ER) Stress Response 
Gene Description 
Fold 
upregulation 
Atf4 Activating transcription factor 4 1.55 
Atf6 Activating transcription factor 6 1.26 
Casp3 Caspase 3 1.78 
Casp12 Caspase 12 2.53 
Ddit3/Chop DNA-damage-inducible transcript 3 26.10 
Dapk1 Death associated protein kinase 1 1.48 
Edem1 ER degradation enhancer, mannosidase alpha-like 1 1.22 
Ero1l Endoplasmic oxidoreductin-1-like protein 2.19 
Gadd34 Growth arrest and DNA-damage-inducible 34 2.53 
Gadd45b Growth arrest and DNA-damage-inducible 45 beta 6.14 
Herpud1 Homocysteine-inducible, ER stress-inducible, 
ubiquitin-like domain member 1 
1.1 
Jnk1 Mitogen-activated protein kinase 8 1.38 
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Figure 7.3 ER stress response proteins, DNA-damage-inducible transcript 3 (CHOP, 
A) and cytochrome c (CYCS), are highly expressed in caseous human pulmonary TB 
granulomas.  The immunohistology on cryosections (A, CHOP in red, nuclei in blue) 
and paraffin-embedded sections (B, CYCS in green, nuclei in blue, image was taken 
by using 20× lens) was performed as described in Chapter three.       
Caseum 
A 
B 
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Another interesting theme emerging from microarray analysis on human TB 
granulomas is cell transmigration.  Though not complete, the recruitment of 
leukocytes to the site of Mtb infection is known to be driven by various cytokines and 
chemokines including TNF-α, CCL2, CCL3, and CXCL9 [10-11].  The murine 
TDM-granulomas showed the massive infiltration of leukocytes to TDM-bearing 
polystyrene beads (Chapter six and Figure 7.4); we used TDM-granulomas to identify 
molecules that trigger cell transmigration.  At day 6 post-inoculation, murine 
phosphatidylglycerol (PG)- and TDM-granulomas were excised and incubated in 
Dulbecco’s Modified Eagle Medium (DMEM, without phenol red) for 24 to 48 hours.  
The conditioned medium was harvested and size-fractionated.  We tested fractionated- 
conditioned medium by using the Transwell system; conditioned medium is placed in 
the lower compartment and murine bone marrow-derived macrophages are added onto 
the Matrigel matrix (contains extracellular matrix) (Figure 7.5).  Conditioned medium 
from PG-granulomas did not show any activity, whereas conditioned medium 
harvested from TDM-granulomas triggered substantial cell transmigration.   
Interestingly, fractions containing molecules larger than 50 kDa triggered cell 
transmigration; molecules rather than small chemokines seem to play a role in this 
process.  We have identified 144 molecules in the fraction by mass spectrometric 
analysis and are currently investigating candidate molecules.  It is noteworthy that 
molecules (larger than 50 kDa) identified in the fraction are also implicated in the 
transcriptional profiles of human TB granulomas and murine TDM-granulomas (data 
not shown).  These data indicate, to a certain extent, that molecules or pathways of cell 
transmigration are common to both human TB granulomas and murine TDM 
granulomas.   
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Figure 7.4 Trehalose dimycolate recruits leukocytes to the site of injection in mice.  
Phosphatidylglycerol (PG) or trehalose dimycolate (TDM) was coated onto 
polystyrene beads and resuspended in Matrigel matrix.  The mixture was injected into 
mice subcutaneously, and formed granulomas were harvested at day 6.  PG (A) does 
not recruit leukocytes, whereas TDM (B) causes a massive infiltration of leukocytes.  
Detailed methods are described in Chapter six.  Hematoxylin & eosin staining 
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Figure 7.5 Conditioned medium derived from trehalose dimycolate (TDM)-
granulomas triggers cell transmigration.  This work is being done in collaboration with 
Dr. Ute Schwab. 
TDM-granulomas harvested from C57BL/6 mice were ex vivo incubated in 
Dulbecco’s Modified Eagle Medium (DMEM) for 24 to 48 hours (A).  The 
conditioned medium was placed in the lower compartment of the Transwell system, 
and the polycarbonate membrane of Transwell was coated with Matrigel matrix (BD) 
(B).  Murine bone-marrow derived macrophages (C57BL/6) which were added onto 
the top of Matrigel matrix transmigrated through the Matrigel matrix (B&C).  The 
transmigrating macrophages show filopodia in the Matrigel matrix (D, hematoxylin & 
eosin staining).       
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Figure 7.6 A model illustrating the linkages between Mtb-infection, foam cell 
formation and accumulation of caseum in the human TB granuloma.  
A. Intracellular Mtb bacilli synthesize and release cell wall components inside their 
host cells.  We have demonstrated previously that these lipids accumulate in the 
internal vesicles in multi- vesicular bodies, which are exocytosed from the cell in 
vesicular form B. Because of the release of these vesicles, both infected and 
uninfected macrophages are exposed to cell wall mycolates and induced to form 
foamy macrophages, as illustrated in Figure 5.  The foamy macrophages have been 
shown to support the maintenance and growth of persistent bacteria C. We now 
propose that these cells die via an inflammatory, necrotic process and release their 
lipid droplets into the extracellular milieu within the granuloma.  As a result of the 
fibrotic capsule, the human granuloma is an enclosed, isolated structure with minimal 
vasculature.  The enclosed nature of the human granuloma leads to accumulation of 
necrotic debris as caseum.  In this model, this process is an integral part of the 
pathology that leads to active disease and transmission.   
Kim MJ, Wainwright HC, Locketz M, Bekker LG, Walther GB, Dittrich C, Visser A, 
Wang W, Hsu FF, Wiehart U, Tsenova L, Kaplan G, and Russell DG.   
In press (EMBO molecular medicine) 
 
 
 195 
 
Conclusion 
Overall, this work has presented a better understanding of the biology of TB 
granulomas, by using molecular, histological, biochemical, and cell biological 
methods in vitro and in vivo.  Based on our data, we propose a new model for the 
progression of TB granulomas; Mtb infection drives the dysregulation of host lipid 
metabolism, thereby leading to the accumulation of lipids within cells (mainly 
macrophages); furthermore, cell death (including ER stress-induced apoptosis and 
necrosis) causes the release of sequestered lipids, which ultimately results in the 
formation of a caseum (Figure 7.6).  The data from human TB granulomas will 
provide opportunities for designing novel therapeutics targeting Mtb and/or 
modulating host metabolism.   
Many questions need to be answered.  For example: Are other molecules 
important roles in lipid metabolism within human TB granulomas? Is there a direct 
relationship between upregulation of ADFP, ACSL1, and SapC and accumulation of 
neutral lipids and glycosphingolipids?  Which other lipids are present in the caseum?  
Are the lipids in the caseum made of lipids derived from foam cells?  Can Mtb bacilli 
metabolize the lipids in the caseum of human TB granulomas or are the accumulated 
lipids a byproduct of the host immune response?  How does cell death within TB 
granulomas occur?  Is there a way of preventing the caseum formation and granuloma 
breakdown?  
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